1

Prof. A Doria, University of Padova, Italy 1. Doria A, Bass D, Schwarting A, Hammer A, Gordon D, Scheinberg M, Fox NL,

Groark J, Stohl W, Kleoudis C, Roth D. A 6-month open-label extension study of the safety and efficacy of subcutaneous belimumab in patients with systemic lupus erythematosus. Lupus. 2018 Jan 1:961203318777634. doi: 10.1177/0961203318777634. [Epub ahead of print] PubMed PMID: 29807477.

2. Sebastiani GD, Prevete I, Iuliano A, Piga M, Iannone F, Coladonato L, Govoni M, Bortoluzzi A, Mosca M, Tani C, Doria A, Iaccarino L, Tincani A, Fredi M, Conti F, Spinelli FR, Galeazzi M, Bellisai F, Zanetti A, Carrara G, Scirè CA, Mathieu A. Early Lupus Project: one-year follow-up of an Italian cohort of patients with systemic lupus erythematosus of recent onset. Lupus. 2018 Jan 1:961203318777112. doi: 10.1177/0961203318777112. [Epub ahead of print] PubMed PMID: 29779436.

3. Trentin F, Gatto M, Zen M, Larosa M, Nalotto L, Saccon F, Zanatta E, Iaccarino L, Doria A. Correction to: Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies. Clin Rev Allergy Immunol. 2018 Apr 16. doi: 10.1007/s12016-018-8682-3. [Epub ahead of print] PubMed PMID: 29736902.

4. Moroni G, Vercelloni PG, Quaglini S, Gatto M, Gianfreda D, Sacchi L, Raffiotta F, Zen M, Costantini G, Urban ML, Pieruzzi F, Messa P, Vaglio A, Sinico RA, Doria A. Changing patterns in clinical histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis. Ann Rheum Dis. 2018 May 5. pii: annrheumdis-2017-212732. doi: 10.1136/annrheumdis-2017-212732. [Epub ahead of print] PubMed PMID: 29730634.

5. Pregnolato F, Borghi MO, Meroni PL; Forum Interdisciplinare per la Ricerca sulle Malattie Autoimmuni (FIRMA) Study Group. Pitfalls of antinuclear antibody detection in systemic lupus erythematosus: the positive experience of a national multicentre study. Ann Rheum Dis. 2018 Apr 25. pii: annrheumdis-2018-213516. doi: 10.1136/annrheumdis-2018-213516. [Epub ahead of print] PubMed PMID: 29695499.

6. Doria A, Stohl W, Schwarting A, Okada M, Scheinberg M, van Vollenhoven R, Hammer AE, Groark J, Bass D, Fox NL, Roth D, Gordon D. Efficacy and Safety of Subcutaneous Belimumab in Anti-Double-Stranded DNA-Positive, Hypocomplementemic Patients With Systemic Lupus Erythematosus. Arthritis Rheumatol. 2018 Apr 18. doi: 10.1002/art.40511. [Epub ahead of print] PubMed PMID: 29671280.

7. Zen M, Doria A. Response to: 'Remission or low disease activity as a target in systemic lupus erythematosus' by Ugarte-Gil et al. Ann Rheum Dis. 2018 Jan 17. pii: annrheumdis-2017-212911. doi: 10.1136/annrheumdis-2017-212911. [Epub ahead of print] PubMed PMID: 29343511.

8. Lightstone L, Doria A, Wilson H, Ward FL, Larosa M, Bargman JM. Can we manage lupus nephritis without chronic corticosteroids administration? Autoimmun Rev 2018; 17(1):4-10. doi: 10.1016/j.autrev.2017.11.002. Epub 2017 Nov 3. Review. PubMed PMID: 29108828.

9. Doria A, Gatto M, Iaccarino L, Sarzi-Puttini P. Controversies in Rheumatology and Autoimmunity: Approaching the truth by the discussion. Autoimmun Rev

2

2018;17(1):1-3. doi:10.1016/j.autrev.2017.11.001. Epub 2017 Nov 3. PubMed PMID:29108827.

10. Atzeni F, Pipitone N, Iaccarino L, Masala IF, Weiss R, Alciati A, Doria A, Chapmanand J, Sarzi-Puttini P. Rheumatic diseases and autoimmune vasculardementia. Autoimmun Rev 2017 16(12):1265-1269. doi:10.1016/j.autrev.2017.10.011. Epub 2017 Oct 14. Review. PubMed PMID: 29037904.

11. Talotta R, Berzi A, Doria A, Batticciotto A, Ditto MC, Atzeni F, Sarzi-Puttini P, Trabattoni D. The Immunogenicity of Branded and Biosimilar Infliximab in Rheumatoid Arthritis According to Th9-Related Responses. Int J Mol Sci 2017;18(10). pii: E2127. doi: 10.3390/ijms18102127. PubMed PMID: 29023386; PubMed Central PMCID: PMC5666809.

12. Zen M, Iaccarino L, Gatto M, Saccon F, Larosa M, Ghirardello A, Punzi L, Doria A. Lupus low disease activity state is associated with a decrease in damage progression in Caucasian patients with SLE, but overlaps with remission. Ann Rheum Dis. 2018 Jan;77(1):104-110. doi: 10.1136/annrheumdis-2017-211613. Epub 2017 Sep 26. PubMed PMID: 28970217.

13. Iaccarino L, Andreoli L, Bocci EB, Bortoluzzi A, Ceccarelli F, Conti F, De Angelis R, De Marchi G, De Vita S, Di Matteo A, Emmi G, Emmi L, Gatto M, Gerli R, Gerosa M, Govoni M, Larosa M, Meroni PL, Mosca M, Pazzola G, Reggia R, Saccon F, Salvarani C, Tani C, Zen M, Frigo AC, Tincani A, Doria A. Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study. J Autoimmun. 2018 Jan;86:1-8. doi: 10.1016/j.jaut.2017.09.004. Epub 2017 Sep 19. PubMed PMID: 28935492.

14. Doria A, Gatto M, Iaccarino L, Sarzi-Puttini P. Unresolved and critical issues in autoimmune rheumatic diseases. Autoimmun Rev. 2017;16(11):1093-1095. doi: 10.1016/j.autrev.2017.09.001. Epub 2017 Sep 12. PubMed PMID: 28919456.

15. Doria A, Cervera R, Gatto M, Chehab G, Schneider M. The new targeted therapy in systemic lupus erythematosus: Is the glass half-full or half-empty? Autoimmun Rev 2017; 16(11):1119-1124. doi: 10.1016/j.autrev.2017.09.006. Epub 2017 Sep 9. Review. PubMed PMID: 28899802.

16. Zen M, Gatto M, Nalotto L, Larosa M, Iaccarino L, Doria A. The Management of Systemic Lupus Erythematosus (SLE) Patients in Remission. Isr Med Assoc J 2017; 19(7):454-458. Review. PubMed PMID: 28786263.

17. Cavagna L, Monti S, Caporali R, Gatto M, Iaccarino L, Doria A. How I treat idiopathic patients with inflammatory myopathies in the clinical practice. Autoimmun Rev. 2017 Oct;16(10):999-1007. doi: 10.1016/j.autrev.2017.07.016. Epub 2017 Aug 2. Review. PubMed PMID: 28778704.

18. González-Gay MA, Montecucco C, Selva-O'Callaghan A, Trallero-Araguas E, Molberg O, Andersson H, Rojas-Serrano J, Perez-Roman DI, Bauhammer J, Fiehn C, Neri R, Barsotti S, Lorenz HM, Doria A, Ghirardello A, Iannone F, Giannini M, Franceschini F, Cavazzana I, Triantafyllias K, Benucci M, Infantino M, Manfredi M, Conti F, Schwarting A, Sebastiani G, Iuliano A, Emmi G, Silvestri E, Govoni M,Scirè CA, Furini F, Lopez-Longo FJ, Martínez-Barrio J, Sebastiani M, Manfredi A, Bachiller-Corral J, Sifuentes Giraldo WA, Cimmino MA, Cosso C, Belotti Masserini A, Cagnotto G, Codullo V, Romano M, Paolazzi G, Pellerito R, Saketkoo

3

LA, Ortego-Centeno N, Quartuccio L, Batticciotto A, Bartoloni Bocci E, Gerli R, Specker C, Bravi E, Selmi C, Parisi S, Salaffi F, Meloni F, Marchioni E, Pesci A, Dei G, Confalonieri M, Tomietto P, Nuno L, Bonella F, Pipitone N, Mera-Valera A, Perez-Gomez N, Gerzeli S, Lopez-Mejias R, Matos-Costa CJ, Pereira da Silva JA,Cifrian J, Alpini C, Olivieri I, Blázquez Cañamero MÁ, Rodriguez Cambrón AB, Castañeda S, Cavagna L; AENEAS (American and European NEtwork of Antisynthetase Syndrome) collaborative group. Timing of onset affects arthritis presentation pattern in antisyntethase syndrome. Clin Exp Rheumatol. 2017 Jul 26. [Epub ahead of print] PubMed PMID: 28770709.

19. Langefeld CD, Ainsworth HC, Graham DSC, Kelly JA, Comeau ME, Marion MC, Howard TD, Ramos PS, Croker JA, Morris DL, Sandling JK, Almlöf JC, Acevedo-Vásquez EM, Alarcón GS, Babini AM, Baca V, Bengtsson AA, Berbotto GA, Bijl M, Brown EE, Brunner HI, Cardiel MH, Catoggio L, Cervera R, Cucho-Venegas JM, Dahlqvist SR, D'Alfonso S, Da Silva BM, de la Rúa Figueroa I, Doria A, Edberg JC, Endreffy E, Esquivel-Valerio JA, Fortin PR, Freedman BI, Frostegård J, García MA, de la Torre IG, Gilkeson GS, Gladman DD, Gunnarsson I, Guthridge JM, Huggins JL, James JA, Kallenberg CGM, Kamen DL, Karp DR, Kaufman KM, Kottyan LC, Kovács L, Laustrup H, Lauwerys BR, Li QZ, Maradiaga-Ceceña MA, Martín J, McCune JM, McWilliams DR, Merrill JT, Miranda P, Moctezuma JF, Nath SK, Niewold TB, Orozco L, Ortego-Centeno N, Petri M, Pineau CA, Pons-Estel BA, Pope J, Raj P, Ramsey-Goldman R, Reveille JD, Russell LP, Sabio JM, Aguilar-Salinas CA, Scherbarth HR, Scorza R, Seldin MF, Sjöwall C, Svenungsson E, Thompson SD, Toloza SMA, Truedsson L, Tusié-Luna T, Vasconcelos C, Vilá LM, Wallace DJ, Weisman MH, Wither JE, Bhangale T, Oksenberg JR, Rioux JD, Gregersen PK, Syvänen AC, Rönnblom L, Criswell LA, Jacob CO, Sivils KL, Tsao BP, Schanberg LE, Behrens TW, Silverman ED, Alarcón-Riquelme ME, Kimberly RP, Harley JB, Wakeland EK, Graham RR, Gaffney PM, Vyse TJ. Transancestral mapping and genetic load in systemic lupus erythematosus. Nat Commun. 2017 Jul 17;8:16021. doi: 10.1038/ncomms16021. PubMed PMID: 28714469.

20. Giacomelli R, Afeltra A, Alunno A, Baldini C, Bartoloni-Bocci E, Berardicurti O, Carubbi F, Cauli A, Cervera R, Ciccia F, Cipriani P, Conti F, De Vita S, Di Benedetto P, Doria A, Drosos AA, Favalli EG, Gandolfo S, Gatto M, Grembiale RD, Liakouli V, Lories R, Lubrano E, Lunardi C, Margiotta DPE, Massaro L, Meroni P, Minniti A, Navarini L, Pendolino M, Perosa F, Pers JO, Prete M, Priori R, Puppo F, Quartuccio L, Ruffatti A, Ruscitti P, Russo B, Sarzi-Puttini P, Shoenfeld Y, Somarakis GA, Spinelli FR, Tinazzi E, Triolo G, Ursini F, Valentini G, Valesini G, Vettori S, Vitali C, Tzioufas AG. International consensus: what else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. Autoimmun Rev. 2017 Jul 10. pii: S1568-9972(17)30183-0. doi: 10.1016/j.autrev.2017.07.012. [Epub ahead of print] Review. PubMed PMID: 28705780.

21. Gatto M, Iaccarino L, Zen M, Doria A. When to use belimumab in SLE. Expert Rev Clin Immunol. 2017 Aug;13(8):737-740. doi: 10.1080/1744666X.2017.1324784. Epub 2017 May 5. PubMed PMID: 28463023.

22. Kleinmann JF, Tubach F, Le Guern V, Mathian A, Richez C, Saadoun D, Sacre K, Sellam J, Seror R, Amoura Z, Andres E, Audia S, Bader-Meunier B, Blaison G, Bonnotte B, Cacoub P, Caillard S, Chiche L, Chosidow O, Costedoat-Chalumeau N,

4

Daien C, Daugas E, Derdèche N, Doria A, Fain O, Fakhouri F, Farge D, Gabay C, Guillo S, Hachulla E, Hajjaj-Hassouni N, Hamidou M, Houssiau FA, Jourde-Chiche N, Koné-Paut I, Ladjouz-Rezig A, Lambotte O, Lipsker D, Mariette X, Martin-Silva N, Martin T, Maurier F, Meckenstock R, Mékinian A, Meyer O, Mohamed S, Morel J, Moulin B, Mulleman D, Papo T, Poindron V, Puéchal X, Punzi L, Quartier P, Sailler L, Smail A, Soubrier M, Sparsa A, Tazi-Mezalek Z, Zakraoui L, Zuily S, Sibilia J, Gottenberg JE. International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus. Autoimmun Rev. 2017 Jun;16(6):650-657. doi: 10.1016/j.autrev.2017.04.011. Epub 2017 Apr 18. Review. PubMed PMID: 28434948.

23. Raffeiner B, Grisan E, Botsios C, Stramare R, Rizzo G, Bernardi L, Punzi L, Ometto F, Doria A. Grade and location of power Doppler are predictive of damage progression in rheumatoid arthritis patients in clinical remission by anti-tumour necrosis factor α. Rheumatology (Oxford). 2017 Apr 20. doi: 10.1093/rheumatology/kex084. [Epub ahead of print] PubMed PMID: 28431141.

24. Stohl W, Schwarting A, Okada M, Scheinberg M, Doria A, Hammer AE, Kleoudis C, Groark J, Bass D, Fox NL, Roth D, Gordon D. Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled Study. Arthritis Rheumatol. 2017 May;69(5):1016-1027. doi: 10.1002/art.40049. Epub 2017 Apr 7. PubMed PMID: 28118533; PubMed Central PMCID: PMC5434872.

25. Rothwell S, Cooper RG, Lundberg IE, Gregersen PK, Hanna MG, Machado PM, Herbert MK, Pruijn GJM, Lilleker JB, Roberts M, Bowes J, Seldin MF, Vencovsky J, Danko K, Limaye V, Selva-O'Callaghan A, Platt H, Molberg Ø, Benveniste O, Radstake TRDJ, Doria A, De Bleecker J, De Paepe B, Gieger C, Meitinger T, Winkelmann J, Amos CI, Ollier WE, Padyukov L, Lee AT, Lamb JA, Chinoy H; Myositis Genetics Consortium. Immune-Array Analysis in Sporadic Inclusion Body Myositis Reveals HLA-DRB1 Amino Acid Heterogeneity Across the Myositis Spectrum. Arthritis Rheumatol. 2017 May;69(5):1090-1099. doi: 10.1002/art.40045. Epub 2017 Apr 4. PubMed PMID: 28086002.

26. Fiocco U, Stramare R, Martini V, Coran A, Caso F, Costa L, Felicetti M, Rizzo G, Tonietto M, Scanu A, Oliviero F, Raffeiner B, Vezzù M, Lunardi F, Scarpa R, Sacerdoti D, Rubaltelli L, Punzi L, Doria A, Grisan E. Quantitative imaging by pixel-based contrast-enhanced ultrasound reveals a linear relationship between synovial vascular perfusion and the recruitment of pathogenic IL-17A-F(+)IL-23(+) CD161(+) CD4(+) T helper cells in psoriatic arthritis joints. Clin Rheumatol. 2016 Dec 20. [Epub ahead of print] PubMed PMID: 27995384.

27. Ometto F, Friso L, Astorri D, Botsios C, Raffeiner B, Punzi L, Doria A. Calprotectin in rheumatic diseases. Exp Biol Med (Maywood). 2016 Nov 28. pii: 1535370216681551. [Epub ahead of print] PubMed PMID: 27895095.

28. van Vollenhoven R, Voskuyl A, Bertsias G, Aranow C, Aringer M, Arnaud L, Askanase A, Balážová P, Bonfa E, Bootsma H, Boumpas D, Bruce I, Cervera R, Clarke A, Coney C, Costedoat-Chalumeau N, Czirják L, Derksen R, Doria A, Dörner T, Fischer-Betz R, Fritsch-Stork R, Gordon C, Graninger W, Györi N, Houssiau F, Isenberg D, Jacobsen S, Jayne D, Kuhn A, Le Guern V, Lerstrøm K, Levy R, Machado-Ribeiro F, Mariette X, Missaykeh J, Morand E, Mosca M, Inanc M, Navarra S, Neumann I, Olesinska M, Petri M, Rahman A, Rekvig OP, Rovensky J, Shoenfeld Y, Smolen J, Tincani A, Urowitz M, van Leeuw B, Vasconcelos C, Voss A, Werth VP, Zakharova H, Zoma A, Schneider M, Ward M. A framework for

5

remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS). Ann Rheum Dis. 2016 Nov 24. pii: annrheumdis-2016-209519. doi: 10.1136/annrheumdis-2016-209519. [Epub ahead of print] PubMed PMID: 27884822.

29. Zen M, Iaccarino L, Gatto M, Bettio S, Saccon F, Ghirardello A, Punzi L, Doria A. The effect of different durations of remission on damage accrual: results from a prospective monocentric cohort of Caucasian patients. Ann Rheum Dis. 2016 Nov 24. pii: annrheumdis-2016-210154. doi: 10.1136/annrheumdis-2016-210154. [Epub ahead of print] PubMed PMID: 27884821.

30. de Hooge M, Ramonda R, Lorenzin M, Frallonardo P, Punzi L, Ortolan A, Doria A. Work productivity is associated with disease activity and functional ability in Italian patients with early axial spondyloarthritis: an observational study from the SPACE cohort. Arthritis Res Ther. 2016 Nov 16;18(1):265. PubMed PMID: 27852321; PubMed Central PMCID: PMC5112652.

31. Doria A, Gershwin ME, Selmi C. From old concerns to new advances and personalized medicine in lupus: The end of the tunnel is approaching. J Autoimmun. 2016 Nov;74:1-5. doi: 10.1016/j.jaut.2016.08.007. PubMed PMID: 27592380.

32. Moroni G, Doria A, Giglio E, Tani C, Zen M, Strigini F, Zaina B, Tincani A, de Liso F, Matinato C, Grossi C, Gatto M, Castellana P, Limardo M, Meroni PL, Messa P, Ravani P, Mosca M. Fetal outcome and recommendations of pregnancies in lupus nephritis in the 21st century. A prospective multicenter study. J Autoimmun. 2016 Nov;74:6-12. doi: 10.1016/j.jaut.2016.07.010. PubMed PMID: 27496151

33. Gatto M, Ghirardello A, Luisetto R, Bassi N, Fedrigo M, Valente M, Valentino S, Del Prete D, Punzi L, Doria A. Immunization with pentraxin 3 (PTX3) leads to anti-PTX3 antibody production and delayed lupus-like nephritis in NZB/NZW F1 mice. J Autoimmun. 2016 Nov;74:208-216. doi: 10.1016/j.jaut.2016.07.002. PubMed PMID: 27405845.

34. Gatto M, Saccon F, Zen M, Bettio S, Iaccarino L, Punzi L, Doria A. Success and failure of biological treatment in systemic lupus erythematosus: A critical analysis. J Autoimmun. 2016 Nov;74:94-105. doi: 10.1016/j.jaut.2016.06.014. Review. PubMed PMID: 27373904.

35. Moroni G, Doria A, Giglio E, Imbasciati E, Tani C, Zen M, Strigini F, Zaina B, Tincani A, Gatto M, de Liso F, Grossi C, Meroni PL, Cabiddu G, Messa P, Ravani P, Mosca M. Maternal outcome in pregnant women with lupus nephritis. A prospective multicenter study. J Autoimmun. 2016 Nov;74:194-200. doi: 10.1016/j.jaut.2016.06.012. PubMed PMID: 27373903

36. Saccon F, Gatto M, Ghirardello A, Iaccarino L, Punzi L, Doria A. Role of galectin-3 in autoimmune and non-autoimmune nephropathies. Autoimmun Rev. 2017 Jan;16(1):34-47. doi: 10.1016/j.autrev.2016.09.023. Review. PubMed PMID: 27666815.

37. Ghirardello A, Bettio S, Bassi N, Gatto M, Beggio M, Lundberg I, Vattemi G, Iaccarino L, Punzi L, Doria A. Autoantibody testing in patients with myositis: clinical accuracy of a multi parametric line immunoassay. Clin Exp Rheumatol. 2016 Sep 8. [Epub ahead of print] PubMed PMID: 27749219.

6

38. Doria A, Zen M, Iaccarino L. Remission in SLE: the duration depends on multiple factors, including the definition. Ann Rheum Dis. 2016 Dec;75(12):e77. doi: 10.1136/annrheumdis-2016-210502. PubMed PMID: 27707731.

39. Rydén-Aulin M, Boumpas D, Bultink I, Callejas Rubio JL, Caminal-Montero L, Castro A, Colodro Ruiz A, Doria A, Dörner T, Gonzalez-Echavarri C, Gremese E, Houssiau FA, Huizinga T, Inanç M, Isenberg D, Iuliano A, Jacobsen S, Jimenéz-Alonso J, Kovács L, Mariette X, Mosca M, Nived O, Oristrell J, Ramos-Casals M, Rascón J, Ruiz-Irastorza G, Sáez-Comet L, Salvador Cervelló G, Sebastiani GD, Squatrito D, Szücs G, Voskuyl A, van Vollenhoven R. Off-label use of rituximab for systemic lupus erythematosus in Europe. Lupus Sci Med. 2016 Sep 6;3(1):e000163. doi: 10.1136/lupus-2016-000163. PubMed PMID: 27651920; PubMed Central PMCID: PMC5013507.

40. Musset L, Allenbach Y, Benveniste O, Boyer O, Bossuyt X, Bentow C, Phillips J, Mammen A, Van Damme P, Westhovens R, Ghirardello A, Doria A, Choi MY, Fritzler MJ, Schmeling H, Muro Y, García-De La Torre I, Ortiz-Villalvazo MA, Bizzaro N, Infantino M, Imbastaro T, Peng Q, Wang G, Vencovský J, Klein M, Krystufkova O, Franceschini F, Fredi M, Hue S, Belmondo T, Danko K, Mahler M. Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study. Autoimmun Rev. 2016 Oct;15(10):983-93. doi: 10.1016/j.autrev.2016.07.023. Review. PubMed PMID: 27491568.

41. Andreoli L, Bertsias GK, Agmon-Levin N, Brown S, Cervera R, Costedoat-Chalumeau N, Doria A, Fischer-Betz R, Forger F, Moraes-Fontes MF, Khamashta M, King J, Lojacono A, Marchiori F, Meroni PL, Mosca M, Motta M, Ostensen M, Pamfil C, Raio L, Schneider M, Svenungsson E, Tektonidou M, Yavuz S, Boumpas D, Tincani A. EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum Dis. 2016 Jul 25. pii: annrheumdis-2016-209770. doi: 10.1136/annrheumdis-2016-209770. [Epub ahead of print] PubMed PMID: 27457513.

42. Iaccarino L, Bettio S, Reggia R, Zen M, Frassi M, Andreoli L, Gatto M, Piantoni S, Nalotto L, Franceschini F, Larosa M, Fredi M, Punzi L, Tincani A, Doria A. Effects of Belimumab on Flare Rate and Expected Damage Progression in Patients With Active Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2016 Jul 7. doi: 10.1002/acr.22971. [Epub ahead of print] PubMed PMID: 27390293.

43. Larosa M, Iaccarino L, Gatto M, Punzi L, Doria A. Advances in the diagnosis and classification of systemic lupus erythematosus. Expert Rev Clin Immunol. 2016 Dec;12(12):1309-1320. PubMed PMID: 27362864.

44. Bindoli S, Dagan A, Torres-Ruiz JJ, Perricone C, Bizjak M, Doria A, Shoenfeld Y. Sarcoidosis and Autoimmunity: From Genetic Background to Environmental Factors. Isr Med Assoc J. 2016 Mar-Apr;18(3-4):197-202. PubMed PMID: 27228643.

45. Gatto M, Iaccarino L, Ghirardello A, Punzi L, Doria A. Clinical and pathologic considerations of the qualitative and quantitative aspects of lupus nephritogenic autoantibodies: A comprehensive review. J Autoimmun. 2016 May;69:1-11. doi: 10.1016/j.jaut.2016.02.003. Review. PubMed PMID: 26879422.

7

46. Houssiau FA, Doria A. Targeting BAFF/BLyS in lupus: is the glass half-full or half-empty? Ann Rheum Dis. 2016 Feb;75(2):321-2. doi: 10.1136/annrheumdis-2015-208312. PubMed PMID: 26590173.

47. Fiocco U, Martini V, Accordi B, Caso F, Costa L, Oliviero F, Scanu A, Felicetti M, Frallonardo P, Facco M, Boso D, Molena B, Zambello R, Ramonda R, Cozzi F, Scarpa R, Basso G, Semenzato G, Dayer JM, Doria A, Punzi L. Ex Vivo Signaling Protein Mapping in T Lymphocytes in the Psoriatic Arthritis Joints. J Rheumatol Suppl. 2015 Nov;93:48-52. doi: 10.3899/jrheum.150636. PubMed PMID: 26523057.

48. Ghirardello A, Gizzo S, Noventa M, Quaranta M, Vitagliano A, Gallo N, Pantano G, Beggio M, Cosma C, Gangemi M, Plebani M, Doria A. Acute immunomodulatory changes during controlled ovarian stimulation: evidence from the first trial investigating the short-term effects of estradiol on biomarkers and B cells involved in autoimmunity. J Assist Reprod Genet. 2015 Dec;32(12):1765-72. doi: 10.1007/s10815-015-0588-x. PubMed PMID: 26466939; PubMed Central PMCID: PMC4681742.

49. Rothwell S, Cooper RG, Lundberg IE, Miller FW, Gregersen PK, Bowes J, Vencovsky J, Danko K, Limaye V, Selva-O'Callaghan A, Hanna MG, Machado PM, Pachman LM, Reed AM, Rider LG, Cobb J, Platt H, Molberg Ø, Benveniste O, Mathiesen P, Radstake T, Doria A, De Bleecker J, De Paepe B, Maurer B, Ollier WE, Padyukov L, O'Hanlon TP, Lee A, Amos CI, Gieger C, Meitinger T, Winkelmann J, Wedderburn LR, Chinoy H, Lamb JA; Myositis Genetics Consortium.. Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups. Ann Rheum Dis. 2016 Aug;75(8):1558-66. doi: 10.1136/annrheumdis-2015-208119. PubMed PMID: 26362759.

50. Zen M, Iaccarino L, Gatto M, Bettio S, Nalotto L, Ghirardello A, Punzi L, Doria A. Prolonged remission in Caucasian patients with SLE: prevalence and outcomes. Ann Rheum Dis. 2015 Dec;74(12):2117-22. doi: 10.1136/annrheumdis-2015-207347. PubMed PMID: 26223434

51. Benvenuti F, Gatto M, Larosa M, Iaccarino L, Punzi L, Doria A. Cardiovascular risk factors, burden of disease and preventive strategies in patients with systemic lupus erythematosus: a literature review. Expert Opin Drug Saf. 2015;14(9):1373-85. doi: 10.1517/14740338.2015.1073259. Review. PubMed PMID: 26212119.

52. de Oliveira FL, Gatto M, Bassi N, Luisetto R, Ghirardello A, Punzi L, Doria A. Galectin-3 in autoimmunity and autoimmune diseases. Exp Biol Med (Maywood). 2015 Aug;240(8):1019-28. doi: 10.1177/1535370215593826. Review. PubMed PMID: 26142116; PubMed Central PMCID: PMC4935288.

53. Iaccarino L, Bartoloni E, Carli L, Ceccarelli F, Conti F, De Vita S, Ferraccioli G, Galeazzi M, Gatto M, Gerli R, Govoni M, Gremese E, Iuliano A, Mansutti E, Moroni G, Mosca M, Nalli C, Naretto C, Padovan M, Palma L, Raffiotta F, Roccatello D, Tincani A, Valesini G, Zen M, Doria A. Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry. Clin Exp Rheumatol. 2015 Jul-Aug;33(4):449-56. PubMed PMID: 26053285.

54. Doria A, Iaccarino L, La Montagna G, Mathieu A, Piga M, Galeazzi M, Iuliano A, Maurel FB, Garofano AM, Perna AG, Porcasi RE. Clinical profile and direct medical cost of care of adults presenting with systemic lupus erythematosus in Italy. Clin Exp Rheumatol. 2015 May-Jun;33(3):375-84. PubMed PMID: 26005879.

8

55. Fredi M, Lazzaroni MG, Tani C, Ramoni V, Gerosa M, Inverardi F, Sfriso P, Caramaschi P, Andreoli L, Sinico RA, Motta M, Lojacono A, Trespidi L, Strigini F, Brucato A, Caporali R, Doria A, Guillevin L, Meroni PL, Montecucco C, Mosca M, Tincani A. Systemic vasculitis and pregnancy: a multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies. Autoimmun Rev. 2015 Aug;14(8):686-91. doi: 10.1016/j.autrev.2015.03.009. Review. PubMed PMID: 25858351.

56. Bassi N, Del Prete D, Ghirardello A, Gatto M, Ceol M, Zen M, Bettio S, Mantovani A, Iaccarino L, Punzi L, Doria A. PTX3, Anti-PTX3, and Anti-C1q Autoantibodies in Lupus Glomerulonephritis. Clin Rev Allergy Immunol. 2015 Oct;49(2):217-26. doi: 10.1007/s12016-015-8476-9. PubMed PMID: 25805362.

57. Doria A, Gatto M, Iaccarino L, Punzi L. Value and goals of treat-to-target in systemic lupus erythematosus: knowledge and foresight. Lupus. 2015 Apr;24(4-5):507-15. doi: 10.1177/0961203314559087. Review. PubMed PMID: 25801894.

58. Bassi N, Luisetto R, Ghirardello A, Gatto M, Valente M, Della Barbera M, Nalotto L, Punzi L, Doria A. 17-β-estradiol affects BLyS serum levels and the nephritogenic autoantibody network accelerating glomerulonephritis in NZB/WF1 mice. Lupus. 2015 Apr;24(4-5):382-91. doi: 10.1177/0961203314559636. PubMed PMID: 25801881.

59. Ometto F, Raffeiner B, Bernardi L, Botsios C, Veronese N, Punzi L, Doria A. Self-reported flares are predictors of radiographic progression in rheumatoid arthritis patients in 28-joint disease activity score remission: a 24-month observational study. Arthritis Res Ther. 2016 Apr 14;18:89. doi: 10.1186/s13075-016-0986-1. Erratum in: Arthritis Res Ther. 2016;18(1):120. PubMed PMID: 27080123; PubMed Central PMCID: PMC4831166.

60. Rojas CM, Borella E, Palma L, Ragozzino S, De Ramón E, Gomez-Huelgas R, Punzi L, Doria A. Bronchiolitis obliterans organizing pneumonia in patients with autoimmune rheumatic diseases. Immunol Res. 2015 Feb;61(1-2):97-103. doi: 10.1007/s12026-014-8607-z. Review. PubMed PMID: 25480740.

61. Caforio AL, Angelini A, Blank M, Shani A, Kivity S, Goddard G, Doria A, Schiavo A, Testolina M, Bottaro S, Marcolongo R, Thiene G, Iliceto S, Shoenfeld Y. Passive transfer of affinity-purified anti-heart autoantibodies (AHA) from sera of patients with myocarditis induces experimental myocarditis in mice. Int J Cardiol. 2015 Jan 20;179:166-77. doi: 10.1016/j.ijcard.2014.10.165. PubMed PMID: 25464438.

62. Borella E, Palma L, Zen M, Bettio S, Nalotto L, Gatto M, Domeneghetti M, Laccarino L, Punzi L, Doria A. The body against self: autoinflammation and autoimmunity. Isr Med Assoc J. 2014 Oct;16(10):608-10. PubMed PMID: 25438443

63. Di Gangi M, Amato G, Converso G, Benenati A, Leonetti C, Borella E, Doria A, Foti R. Long-term efficacy of adalimumab in hyperimmunoglobulin D and periodic fever syndrome. Isr Med Assoc J. 2014 Oct;16(10):605-7. PubMed PMID: 25438442.

64. Borella E, Lojacono A, Gatto M, Andreoli L, Taglietti M, Iaccarino L, Casiglia E, Punzi L, Tincani A, Doria A. Predictors of maternal and fetal complications in SLE patients: a prospective study. Immunol Res. 2014 Dec;60(2-3):170-6. doi: 10.1007/s12026-014-8572-6. PubMed PMID: 25398639

9

65. Iaccarino L, Shoenfeld N, Rampudda M, Zen M, Gatto M, Ghirardello A, Bassi N, Punzi L, Shoenfeld Y, Doria A. The olfactory function is impaired in patients with idiopathic inflammatory myopathies. Immunol Res. 2014 Dec;60(2-3):247-52. doi: 10.1007/s12026-014-8581-5. PubMed PMID: 25391613

66. Da Silva Domingues V, Iaccarino L, Briani C, Caso F, Vasconcelos C, Doria A. Scleromyxedema complicated by dermato-neuro syndrome during pregnancy. Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-234-5. PubMed PMID: 25372807

67. Bortoluzzi A, Scirè CA, Bombardieri S, Caniatti L, Conti F, De Vita S, Doria A, Ferraccioli G, Gremese E, Mansutti E, Mathieu A, Mosca M, Padovan M, Piga M, Tincani A, Tola MR, Tomietto P, Valesini G, Zen M, Govoni M; Study Group on Neuropsychiatric Systemic Lupus Erythematosus of the Italian Society of Rheumatology.. Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus. Rheumatology (Oxford). 2015 May;54(5):891-8. doi: 10.1093/rheumatology/keu384. Review. PubMed PMID: 25339643.

68. Scarsi M, Radice A, Pregnolato F, Ramoni V, Grava C, Bianchi L, Gerosa M, Mosca M, Ghirardello A, Tani C, Motta M, Quinzanini M, Tincani A, Ruffatti A, Migliorini P, Doria A, Meroni PL, Brucato A. Anti-Ro/SSA-p200 antibodies in the prediction of congenital heart block. An Italian multicentre cross-sectional study on behalf of the 'Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) Group'. Clin Exp Rheumatol. 2014 Nov-Dec;32(6):848-54. PubMed PMID: 25327946.

69. Bourji K, Gatto M, Cozzi F, Doria A, Punzi L. Rheumatic and autoimmune thyroid disorders: a causal or casual relationship? Autoimmun Rev. 2015 Jan;14(1):57-63. Review. PubMed PMID: 25315745.

70. Specchia ML, de Waure C, Gualano MR, Doria A, Turchetti G, Pippo L, Di Nardo F, Capizzi S, Cadeddu C, Kheiraoui F, Iaccarino L, Pierotti F, Palla I, Veneziano MA, Gliubizzi D, Sferrazza A, Nicolotti N, Porcasi R, La Torre G, Di Pietro ML, Ricciardi W. Health Technology Assessment of Belimumab: A New Monoclonal Antibody for the Treatment of Systemic Lupus Erythematosus. Biomed Res Int 2014; 2014:704207. Epub 2014 Aug 17. PubMed PMID: 25243173; PubMed Central PMCID: PMC4150460

71. Benvenuti F, Gatto M, Doria A. A case of progressive multifocal leukoencephalopathy in a lupus patient treated with belimumab - comments on article by Fredericks et al. Lupus. 2014 Aug 8. pii: 0961203314545800. [Epub ahead of print] PubMed PMID: 25107935.

72. Ramonda R, Puato M, Punzi L, Rattazzi M, Zanon M, Balbi G, Ortolan A, Frallonardo P, Faggin E, Plebani M, Zaninotto M, Lorenzin M, Pauletto P, Doria A. Atherosclerosis progression in psoriatic arthritis patients despite the treatment with tumor necrosis factor-alpha blockers: A two-year prospective observational study. Joint Bone Spine. 2014 Apr 1. pii: S1297-319X(14)00049-9. doi: 10.1016/j.jbspin.2014.02.005. [Epub ahead of print] PubMed PMID: 24703399.

73. Giannotti E, Koutsikos K, Pigatto M, Rampudda ME, Doria A, Masiero S. Medium-long-term effects of a specific exercise protocol combined with patient education on spine mobility, chronic fatigue, pain, aerobic fitness and level of disability in fibromyalgia. Biomed Res Int. 2014;2014:474029. doi: 10.1155/2014/474029. Epub 2014 Jan 29. PubMed PMID: 24616894; PubMed Central PMCID: PMC3925511

10

74. Gatto M, Kiss E, Naparstek Y, Doria A. In-/off-label use of biologic therapy in systemic lupus erythematosus. BMC Med. 2014 Feb 17;12:30. doi: 10.1186/1741-7015-12-30. PubMed PMID: 24528782; PubMed Central PMCID: PMC3925951.

75. Doria A, Gatto M, Zen M, Iaccarino L, Punzi L. Optimizing outcome in SLE: treating-to-target and definition of treatment goals. Autoimmun Rev 2014; 13: 770-7.

76. Iaccarino L, Ghirardello A, Bettio S, Zen M, Gatto M, Punzi L, Doria A. The clinical features, diagnosis and classification of dermatomyositis. J Autoimmun 2014; 48-49:122-7.

77. Cervera R, Doria A, Amoura Z, Khamashta M, Schneider M, Guillemin F, Maurel F, Garofano A, Roset M, Perna A, Murray M, Schmitt C, Boucot I. Patterns of systemic lupus erythematosus expression in Europe. Autoimmun Rev 2014; 13: 621-629.

78. Fiocco U, Accordi B, Martini V, Oliviero F, Facco M, Cabrelle A, Piva L, Molena B, Caso F, Costa L, Scanu A, Pagnin E, Atteno M, Scarpa R, Basso G, Semenzato G, Punzi L, Doria A, Dayer JM. JAK/STAT/PKCδ molecular pathways in synovial fluid T lymphocytes reflect the in vivo T helper-17 expansion in psoriatic arthritis. Immunol Res 2014; 58: 61-9.

79. Cozzi A, Doria A, Gisondi P, Girolomoni G. Skin rash and arthritis a simplified appraisal of less common associations. J Eur Acad Dermatol Venereol 2014; 28: 679-88.

80. Caso F, Fiocco U, Costa L, Sfriso P, Punzi L, Doria A. Successful use of rituximab in a young patient with immunoglobulin G4-related disease and refractory scleritis. Joint Bone Spine 2014; 81(2):190-2..

81. Puato M, Ramonda R, Doria A, Rattazzi M, Faggin E, Balbi G, Zanon M, Zanardo M, Tirrito C, Lorenzin M, Modesti V, Plebani M, Zaninotto M, Punzi L, Pauletto P. Impact of hypertension on vascular remodeling in patients with psoriatic arthritis. J Hum Hypertens 2014; 28(2):105-10.

82. Doria A, Amoura Z, Cervera R, Khamastha MA, Schneider M, Richter J, Guillemin F, Kobelt G, Maurel F, Garofano A, Perna A, Murray M, Schmitt C, Boucot I. Annual direct medical cost of active systemic lupus erythematosus in five European countries. Ann Rheum Dis 2014; 73: 154-60.

83. Iaccarino L, Bettio S, Zen M, Nalotto L, Gatto M, Ramonda R, Punzi L, Doria A. Premature coronary heart disease in SLE: can we prevent progression? Lupus. 2013;22(12):1232-42.

84. Agmon-Levin N, Rosário C, Katz BS, Zandman-Goddard G, Meroni P, Cervera R, Stojanovich L, Blank M, Pierangeli S, Praprotnik S, Meis ED, Seguro LP, Ruffatti A, Pengo V, Tincani A, Doria A, Shoenfeld Y. Ferritin in the antiphospholipid syndrome and its catastrophic variant (cAPS). Lupus 2013; 22: 1327-35

85. Villalta D, Bizzaro N, Bassi N, Zen M, Gatto M, Ghirardello A, Iaccarino L, Punzi L, Doria A. Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease. PLoS One 2013;8(8):e71458.

86. Martin JE, Assassi S, Diaz-Gallo LM, Broen JC, Simeon CP, Castellvi I, Vicente-Rabaneda E, Fonollosa V, Ortego-Centeno N, González-Gay MA, Espinosa G, Carreira P; Spanish Scleroderma Group; SLEGEN consortium; U.S. Scleroderma GWAS group; BIOLUPUS, Camps M, Sabio JM, D'alfonso S, Vonk MC, Voskuyl

11

AE, Schuerwegh AJ, Kreuter A, Witte T, Riemekasten G, Hunzelmann N, Airo P, Beretta L, Scorza R, Lunardi C, Van Laar J, Chee MM, Worthington J, Herrick A, Denton C, Fonseca C, Tan FK, Arnett F, Zhou X, Reveille JD, Gorlova O, Koeleman BP, Radstake TR, Vyse T, Mayes MD, Alarcón-Riquelme ME, Martin J García Portales R, de Ramon E, Fernández-Nebro A, Román-Ivorra J, Beltran E, Castillo MJ, Sánchez-Román J, Vicente E, Díaz B, Trapiella L, Gallego M, Aguirre MA, Callejas-Rubio JL, Ríos R, Castellvi I, Egurbide MV, Espinosa G, Pros A, Navarrete N, Díaz-González F, Hernández V, Andréu JL, Fernández-Castro M, Sáez Comet L, López-Longo FJ, Martinez-Estupiñan L, Rodríguez-Carballeira M, Javier Narváez F, del Carmen Freire M, Vaqueiro I, Alarcón-Riquelme ME, Criswell LA, Harley JB, Jacob CO, Kimberly RP, Langefeld CD, Moser KL, Tsao BP, Vyse TJ, Ying J, Varga J, Hinchcliff M, Gregersen P, Lee AT, Wigley FM, Hummers L, Alarcón-Riquelme M, Lawerys B, Houssiau F, Jacobsen S, Junker P, Laustrup H, Witte T, Moutsopoulos H, Kapsogeorgou EK, Endreffy E, Kovacs L, Steinsson K, Doria A, Meroni PL, Scorza R, D'Alfonso S, Bijl M, Kallenberg C, Vasconcelos C, Silva BM, Martín J, Martín JE, Suárez A, Rua Figueroa I, Pons-Estel G, Frostegård J, Pons-Estel B. A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci. Hum Mol Genet 2013; 22: 4021-9.

87. Doria A, Gatto M, Punzi L. Autophagy in human health and disease. N Engl JMed. 2013; 368(19):1845.

88. Gatto M, Agmon-Levin N, Soriano A, Manna R, Maoz-Segal R, Kivity S, Doria A, Shoenfeld Y. Human papillomavirus vaccine and systemic lupus erythematosus. Clin Rheumatol 2013; 32: 1301-7.

89. Ghirardello A, Bassi N, Palma L, Borella E, Domeneghetti M, Punzi L, Doria A. Autoantibodies in polymyositis and dermatomyositis. Curr Rheumatol Rep 2013; 15: 335.

90. Caso F, Iaccarino L, Bettio S, Ometto F, Costa L, Punzi L, Doria A. Refractory pemphigus foliaceus and Behçet's disease successfully treated with tocilizumab. Immunol Res 2013; 56: 390-7.

91. Nalotto L, Iaccarino L, Zen M, Gatto M, Borella E, Domenighetti M, Punzi L, Doria A. Rituximab in refractory idiopathic inflammatory myopathies and antisynthetase syndrome: personal experience and review of the literature. Immunol Res 2013; 56: 362-70.

92. Tincani A, Andreoli L, Cavazzana I, Doria A, Favero M, Fenini MG, Franceschini F, Lojacono A, Nascimbeni G, Santoro A, Semeraro F, Toniati P, Shoenfeld Y. Novel aspects of Sjögren's syndrome in 2012. BMC Med. 2013 Apr 4;11:93.

93. Cutolo M, Iaccarino L, Doria A, Govoni M, Sulli A, Marcassa C. Efficacy of the switch to modified-release prednisone in rheumatoid arthritis patients treated with standard glucocorticoids. Clin Exp Rheumatol 2013; 31(4): 498-505.

94. Gatto M, Iaccarino L, Ghirardello A, Bassi N, Pontisso P, Punzi L, Shoenfeld Y, Doria A. Serpins, immunity and autoimmunity: old molecules, new functions. Clin Rev Allergy Immunol 2013; 45: 267-80.

95. Zen M, Gatto M, Domeneghetti M, Palma L, Borella E, Iaccarino L, Punzi L, Doria A. Clinical Guidelines and Definitions of Autoinflammatory Diseases: Contrasts and Comparisons with Autoimmunity-a Comprehensive Review. Clin Rev Allergy Immunol 2013; 45: 227-35.

12

96. Gatto M, Zen M, Ghirardello A, Bettio S, Bassi N, Iaccarino L, Punzi L, Doria A. Emerging and critical issues in the pathogenesis of lupus. Autoimmun Rev 2013; 12: 523-36.

97. Iaccarino L, Gatto M, Bettio S, Caso F, Rampudda M, Zen M, Ghirardello A, Punzi L, Doria A. Overlap connective tissue disease syndromes. Autoimmun Rev 2013; 12: 363-73.

98. Bassetto F, Scarpa C, Vindigni V, Doria A. The periprosthetic capsule and connective tissue diseases: a piece in the puzzle of autoimmune/autoinflammatory syndrome induced by adjuvants. Exp Biol Med (Maywood) 2012; 237: 1117-22.

99. Doria A, Gatto M. Nephritogenic-antinephritogenic antibody network in lupus glomerulonephritis. Lupus 2012; 21: 1492-6.

100. Sundel R, Solomons N, Lisk L; Aspreva Lupus Management Study (ALMS) Group: Abud C, Adler S, Alarcón G, Albuquerque E, Almeida F, Alvarellos A, Appel G, Avila H, Blume C, Boletis I, Bonnardeaux A, Braun A, Buyon J, Cervera R, Chen N, Chen S, Contreras G, Da Costa A, Davids R, D'Cruz D, De Ramón E, Deodha A, Dooley MA, Doria A, Dussol B, Emery P, Fiechtner J, Floege J, Fragoso-Loyo H, Furie R, Ghazalli R, Ghossein C, Gilkeson G, Ginzler E, Gordon C, Grossman J, Gu J, Guillevin L, Hatron PY, Herrera G, Hiepe F, Houssiau F, Hübscher O, Hura C, Kaplan J, Kirsztajn G, Kiss E, Kutty GA, Laville M, Lazaro M, Lenz O, Li L, Lightstone L, Lim S, Malaise M, Manzi S, Marcos J, Meyer O, Monge P, Naicker S, Neal N, Neuwelt M, Nicholls K, Olsen N, Ordi-Ros J, Ostrov B, Pestana M, Petri M, Pokorny G, Pourrat J, Qian J, Radhakrishnan J, Rovi B, Sánchez-Guerrero J, Roman JS, Shanahan J, Shergy W, Skopouli F, Spindler A, Striebic C, Sundel R, Swanepoel C, Tan SY, Tate G, Tesaŕ V, Tikly M, Wang H, Yahya R, Yu X, Zhang F, Zoruba D, Carson P, Snaith M, Cattran D. Efficacy of mycophenolate mofetil in adolescent patients with lupus nephritis: evidence from a two-phase, prospective randomized trial. Lupus 2012; 21: 1433-43.

101. Tarricone E, Ghirardello A, Rampudda M, Bassi N, Punzi L, Doria A. Anti-SAE antibodies in autoimmune myositis: identification by unlabelled protein immunoprecipitation in an Italian patient cohort. J Immunol Methods 2012; 384: 128-34.

102. Maestroni S, Di Corato PR, Cumetti D, Chiara DB, Ghidoni S, Prisacaru L, Cantarini L, Imazio M, Penco S, Pedrotti P, Caforio AL, Doria A, Brucato A. Recurrent pericarditis: autoimmune or autoinflammatory? Autoimmun Rev 2012; 12: 60-5.

103. Doria A, Dayer JM, Punzi L. Autoinflammatory diseases: how to put the fire inside the body out? Autoimmun Rev 2012; 12: 1-4.

104. Doria A, Zen M, Bettio S, Gatto M, Bassi N, Nalotto L, Ghirardello A, Iaccarino L, Punzi L. Autoinflammation and autoimmunity: bridging the divide. Autoimmun Rev 2012; 12: 22-30.

105. Cozzi F, Marson P, Cardarelli S, Favaro M, Tison T, Tonello M, Pigatto E, De Silvestro G, Punzi L, Doria A. Prognosis of scleroderma renal crisis: a long-term observational study. Nephrol Dial Transplant 2012; 27: 4398-403.

106. Bertsias GK, Tektonidou M, Amoura Z, Aringer M, Bajema I, Berden JH, Boletis J, Cervera R, Dörner T, Doria A, Ferrario F, Floege J, Houssiau FA, Ioannidis JP, Isenberg DA, Kallenberg CG, Lightstone L, Marks SD, Martini A, Moroni G, Neumann I, Praga M, Schneider M, Starra A, Tesar V, Vasconcelos C, van Vollenhoven RF, Zakharova H, Haubitz M, Gordon C, Jayne D, Boumpas DT;

13

European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association. Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis 2012; 71: 1771-82.

107. Vidalino L, Doria A, Quarta SM, Crescenzi M, Ruvoletto M, Frezzato F, Trentin L, Turato C, Parolin MC, Ghirardello A, Iaccarino L, Cavalletto L, Chemello L, Gatta A, Pontisso P. SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection. Exp Biol Med (Maywood) 2012; 237: 793-802.

108. Visentin MS, Salmaso R, Modesti V, Ometto F, Ruffatti A, Punzi L, Doria A. Parotid, breast, and fascial involvement in a patient who fulfilled the ACR criteria for Churg-Strauss syndrome. Scand J Rheumatol 2012 Aug;41(4):319-21.

109. Zen M, Bassi N, Nalotto L, Canova M, Bettio S, Gatto M, Ghirardello A, Iaccarino L, Punzi L, Doria A. Disease activity patterns in a monocentric cohort of SLE patients: a seven-year follow-up study. Clin Exp Rheumatol 2012; 30: 856-63.

110. Manzi S, Sánchez-Guerrero J, Merrill JT, Furie R, Gladman D, Navarra SV, Ginzler EM, D'Cruz DP, Doria A, Cooper S, Zhong ZJ, Hough D, Freimuth W, Petri MA; on behalf of the BLISS-52 and BLISS-76 Study Groups. Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials. Ann Rheum Dis. 2012; 71: 1833-8.

111. Doria A, Cutolo M, Ghirardello A, Zen M, Villalta D, Tincani A, Punzi L, Iaccarino L, Petri M. Effect of pregnancy on serum cytokines in SLE patients. Arthritis Res Ther 2012; 14(2):R66

112. Bartoloni E, Alunno A, Bistoni O, Bizzaro N, Migliorini P, Morozzi G, Doria A, Mathieu A, Lotzniker M, Allegri F, Riccieri V, Alpini C, Gabrielli A, Tampoia M, Gerli R; On behalf of the Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) investigators. Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: An Italian multicentric study and review of the literature. Autoimmun Rev 2012; 11: 815-20.

113. Bassi N, Luisetto R, Prete DD, Ghirardello A, Ceol M, Rizzo S, Iaccarino L, Gatto M, Valente M, Punzi L, Doria A. Induction of the 'ASIA' syndrome in NZB/NZWF1 mice after injection of complete Freund's adjuvant (CFA). Lupus 2012; 21: 203-9.

114. Taraborelli M, Ramoni V, Brucato A, Airò P, Bajocchi G, Bellisai F, Biasi D, Blagojevic J, Canti V, Caporali R, Caramaschi P, Chiarolanza I, Codullo V, Cozzi F, Cuomo G, Cutolo M, De Santis M, De Vita S, Di Poi E, Doria A, Faggioli P, Favaro M, Ferraccioli G, Ferri C, Foti R, Gerosa A, Gerosa M, Giacuzzo S, Giani L, Giuggioli D, Imazio M, Iudici M, Iuliano A, Leonardi R, Limonta M, Lojacono A, Lubatti C, Cerinic MM, Mazzone A, Meroni M, Meroni PL, Mosca M, Motta M, Muscarà M, Nava S, Padovan M, Pagani G, Paolazzi G, Peccatori S, Ravagnani V, Riccieri V,Rosato E, Rovere-Querini P, Salsano F, Santaniello A, Scorza R, Tani C, Valentini G, Valesini G, Vanoli M, Vigone B, Zeni S, Tincani A; on behalf of the IMPRESS investigators.. Successful pregnancies but a higher risk of preterm births in systemic sclerosis: An Italian multicentric study. Arthritis Rheum 2012; 64: 1970-7.

14

115. Gatto M, Iaccarino L, Canova M, Zen M, Nalotto L, Ramonda R, Punzi L, Doria A. Pregnancy and vasculitis: A systematic review of the literature. Autoimmun Rev Autoimmun Rev 2012; 11: A447-59.

116. Govoni M, Bombardieri S, Bortoluzzi A, Caniatti L, Casu C, Conti F, De Vita S, Doria A, Farina I, Ferraccioli G, Gremese E, Mansutti E, Mosca M, Padovan M, Piga M, Tincani A, Tola MR, Tomietto P, Taglietti M, Trotta F, Valesini G, Zen M, Mathieu A; Italian Society of Rheumatology. Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients. Rheumatology (Oxford) 2012; 51(1):157-68.

117. Doria A, Putterman C, Sarzi-Puttini P, Szekanecz Z, Shoenfeld Y. Controversies in rheumatism and autoimmunity. Autoimmun Rev 2012; 11: 555-7.

118. Costenbader KH, Gay S, Riquelme ME, Iaccarino L, Doria A. Genes, epigenetic regulation and environmental factors: Which is the most relevant in developing autoimmune diseases? Autoimmun Rev 2012; 11: 604-9.

119. Rekvig OP, Putterman C, Casu C, Gao HX, Ghirardello A, Mortensen ES, Tincani A, Doria A. Autoantibodies in lupus: Culprits or passive bystanders? Autoimmun Rev 2012; 11: 596-603.

120. Cervera R, Conti F, Doria A, Iaccarino L, Valesini G. Does sieronegative antiphospholipid syndrome really exist? Autoimmun Rev 2012; 11: 581-4.

121. Dooley MA, Jayne D, Ginzler EM, Isenberg D, Olsen NJ, Wofsy D, Eitner F, Appel GB, Contreras G, Lisk L, Solomons N; ALMS Group (Abud C, Adler S, Alarc G, Albuquerque E, Almeida F, Alvarellos A, Appel G, Avila H, Menchaca JI, Blume C, Boletis I, Bonnardeaux A, Braun A, Buyon J, Cervera R, Chen N, Chen S, Contreras G, Da Costa AG, Davids R, D'Cruz D, De Ramón E, Haya C, Deodhar A, Dooley MA, Doria A, Dussol B, Emery P, Fiechtner J, Floege J, Fragoso-Loyo H, Furie R, Ghazalli R, Ghossein C, Gilkeson G, Ginzler E, Grossman J, Gu J, Guillevin L, Hatron PY, Herrera G, Hiepe F, Houssiau F, Hübscher O, Hura C, Kaplan J, Kirsztajn G, Kiss E, Kutty GA, Laville M, Lazaro M, Lenz O, Li L, Lightstone L, Lim S, Malaise M, Manzi S, Marcos J, Meyer O, Bernard C, Monge P, Naicker S, Neal N, Neuwelt M, Neuwelt CM, Nicholls K, Olsen N, Ordi-Ros J, Ostrov B, Hershey MS, Pestana M, Petri M, Pokorny G, Pourrat J, Qian J, Radhakrishnan J, Rovin B, Sánchez-Guerrero J, Sanchez Roman J, Shanahan J, Shergy W, Skopouli F, Spindler A, Striebich C, Sundel R, Swanepoel C, Tan SY, Tate G, Tesaŕ V, Tikly M, Wang H, Yahya R, Yu X, Zhang F, Zoruba D, Houssay B, Carson P, Snaith M, Cattran D). Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis. N Engl J Med 2011; 365(20):1886-95.

122. Zeher M, Doria A, Lan J, Aroca G, Jayne D, Boletis I, Hiepe F, Prestele H, Bernhardt P, Amoura Z. Efficacy and safety of enteric-coated mycophenolate sodium in combination with two glucocorticoid regimens for the treatment of active lupus nephritis. Lupus 2011; 20:1484-93.

123. Bizzaro N, Allegri F, Alpini C, Doria A, Gerli R, Lotzniker M, Mathieu A, Morozzi G, Bellisai F, Riccieri V, Tampoia M, Migliorini P. Multicentric evaluation of a second generation assay to detect antiviral citrullinated peptide antibodies: a collaborative study by the Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni. J Clin Pathol 2011; 64(12):1139-41.

15

124. Illei GG, Cervera R, Burt RK, Doria A, Hiepe F, Jayne D, Pavletic S, Martin T, Marmont A, Saccardi R, Voskuyl AE, Farge D. Current state and future directions of autologous hematopoietic stem cell transplantation in sistemi lupus erythematosus. Ann Rheum Dis 2011; 70: 2071-4.

125. Musacchio E, Ramonda R, Perissinotto E, Sartori L, Hirsch R, Punzi L, Zambon S, Corti MC, Baggio G, Manzato E, Doria A, Crepaldi G. The impact of knee and hip chondrocalcinosis on disability in older people: the ProVA Study from northeastern Italy. Ann Rheum Dis 2011; 70: 1937-43.

126. Ramonda R, Lo Nigro A, Modesti V, Nalotto L, Musacchio E, Iaccarino L, Punzi L, Doria A. Atherosclerosis in psoriatic arthritis. Autoimmun Rev 2011; 10: 773-8.

127. Iaccarino L, Ghirardello A, Canova M, Zen M, Bettio S, Nalotto L, Punzi L, Doria A. Anti-annexins autoantibodies: Their role as biomarkers of autoimmune diseases. Autoimmun Rev 2011; 10(9): 553-8.

128. Zandman-Goddard G, Orbach H, Agmon-Levin N, Boaz M, Amital H, Szekanecz Z, Szucs G, Rovensky J, Kiss E, Corocher N, Doria A, Stojanovich L, Ingegnoli F,Meroni PL, Rozman B, Gomez-Arbesu J, Blank M, Shoenfeld Y. Hyperferritinemia is Associated with Serologic Antiphospholipid Syndrome in SLE Patients. Clin RevAllergy Immunol 2011 Mar 11. [Epub ahead of print] PubMed PMID: 21394428.

129. Doria A, Sarzi-Puttini P, Szekanecz Z. CORA - Controversies in Rheumatology and Autoimmunity. March 10-12, 2011, Florence, Italy. Clin Exp Rheumatol 2011; 29(1):149-216.

130. Ghirardello A, Villalta D, Morozzi G, Afeltra A, Galeazzi M, Gerli R, Mathieu A, Meroni PL, Pregnolato F, Migliorini P, Radice A, Riccieri V, Ruffatti A, Sebastiani GD, Sinico RA, Tincani A, Doria A. Diagnostic accuracy of currently available anti-double-stranded DNA antibody assays. An Italian multicentre study. Clin Exp Rheumatol 2011; 29(1):50-6.

131. Mosca M, Govoni M, Tomietto P, Aringer M, Boumpas D, Cervera R, Conti F, D'Cruz D, Doria A, De La Fuente D, Galeazzi M, Houssiau F, Huizinga TW, Khamashta MA, Ines L, Catia D, Couto M, Meroni P, Montecucco C, Norkuviene E, Riemekasten G, Rios V, Schneider M, Shoenfeld Y, Steup-Beekman G, Szmyrka-Kaczmarek M, Tani C, Tincani A, Tzioufas A, Voll R, Bencivelli W, Salaffi F, Bombardieri S. The development of a simple questionnaire to screen SLE patients for the presence of neuropsychiatric (NP) symptoms in routine clinical practice. Lupus 2011; 20(5):485-92.

132. Orbach H, Zandman-Goddard G, Boaz M, Agmon-Levin N, Amital H, Szekanecz Z,Szucs G, Rovensky J, Kiss E, Doria A, Ghirardello A, Gomez-Arbesu J, Stojanovich L, Ingegnoli F, Meroni PL, Rozman B, Blank M, Shoenfeld Y. Prolactin and Autoimmunity : Hyperprolactinemia Correlates with Serositis and Anemia in SLE Patients. Clin Rev Allergy Immunol 2011 Feb 3. [Epub ahead of print] PubMed PMID: 21287295.

133. Ruffatti A, Ross TD, Ciprian M, Bertero MT, Salvatore S, Scarpato S,Montecucco C, Rossi S, Caramaschi P, Biasi D, Doria A, Rampudda M, Monica N,Fischetti F, Picillo U, Brucato A, Salvan E, Vittorio P, Meroni P, Tincani A; ;Antiphospholipid Syndrome Study Group of the Italian Society of Rheumatology.Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study. Ann Rheum Dis 2011; 70:1083–1086.

16

134. Zen M, Canova M, Campana C, Bettio S, Nalotto L, Rampudda M, Ramonda R, Iaccarino L, Doria A. The kaleidoscope of glucorticoid effects on immune system. Autoimmun Rev 2011; 10(6): 305-10.

135. Mosca M, Tani C, Aringer M, Bombardieri S, Boumpas D, Cervera R, Doria A, Jayne D, Khamashta MA, Kuhn A, Gordon C, Petri M, Schneider M, Shoenfeld Y, Smolen JS, Talarico R, Tincani A, Ward MM, Werth VP, Carmona L. Development of quality indicators to evaluate the monitoring of SLE patients in routine clinical practice. Autoimmun Rev 2011; 10(7):383-8.

136. Agmon-Levin N, Blank M, Zandman-Goddard G, Orbach H, Meroni PL, Tincani A, Doria A, Cervera R, Miesbach W, Stojanovich L, Barak V, Porat-Katz BS, Amital H, Shoenfeld Y. Vitamin D: an instrumental factor in the anti-phospholipid syndrome by inhibition of tissue factor expression. Ann Rheum Dis 2011; 70(1):145-50.

137. Ghirardello A, Zampieri S, Tarricone E, Iaccarino L, Gorza L, Doria A. Cutting Edge Issues in Polymyositis. Clin Rev Allergy Immunol 2011; 41(2):179-89.

138. Ostensen M, Brucato A, Carp H, Chambers C, Dolhain RJ, Doria A, Förger F, Gordon C, Hahn S, Khamashta M, Lockshin MD, Matucci-Cerinic M, Meroni P, Nelson JL, Parke A, Petri M, Raio L, Ruiz-Irastorza G, Silva CA, Tincani A, Villiger PM, Wunder D, Cutolo M. Pregnancy and reproduction in autoimmune rheumatic diseases. Rheumatology (Oxford) 2011; 50(4):657-64.

139. Doria A, Zen M, Canova M, Bettio S, Bassi N, Nalotto L, Rampudda M, Ghirardello A, Iaccarino L. SLE diagnosis and treatment: When early is early. Autoimmun Rev 2010; 10: 55-60.

140. Ghirardello A, Rampudda M, Ekholm L, Bassi N, Tarricone E, Zampieri S, Zen M, Vattemi GA, Lundberg IE, Doria A. Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay. Rheumatology (Oxford) 2010; 49: 2370-4.

141. Bertsias GK, Ioannidis JP, Aringer M, Bollen E, Bombardieri S, Bruce IN, Cervera R, Dalakas M, Doria A, Hanly JG, Huizinga TW, Isenberg D, Kallenberg C, Piette JC, Schneider M, Scolding N, Smolen J, Stara A, Tassiulas I, Tektonidou M, Tincani A, van Buchem MA, van Vollenhoven R, Ward M, Gordon C, Boumpas DT. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis 2010; 69: 2074-82.

142. Sarzi-Puttini P, Atzeni F, Gerli R, Bartoloni E, Doria A, Barskova T, Matucci-Cerinic M, Sitia S, Tomasoni L, Turiel M. Cardiac involvement in systemic rheumatic diseases: An update. Autoimmun Rev 2010; 9: 849-52.

143. Caforio AL, Brucato A, Doria A, Brambilla G, Angelini A, Ghirardello A, Bottaro S, Tona F, Betterle C, Daliento L, Thiene G, Iliceto S. Anti-heart and anti-intercalated disk autoantibodies: evidence for autoimmunity in idiopathic recurrent acute pericarditis. Heart 2010; 96: 779-84.

144. Bassi N, Ghirardello A, Blank M, Zampieri S, Sarzi-Puttini P, Mantovani A, Shoenfeld Y, Doria A. IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus. Ann Rheum Dis 2010; 69: 1704-10.

145. Amital H, Szekanecz Z, Szücs G, Dankó K, Nagy E, Csépány T, Kiss E, Doria A, Corocher N, Agmon-Levin N, Orbach H, Zandman-Goddard G, Shoenfeld Y. Serum concentrations of 25-OH Vitamin D in SLE patients are inversely related to disease

17

activity- is it time to routinely supplement SLE patients with vitamin D? Ann Rheum Dis 2010; 69: 1155-7.

146. Vitadello M, Doria A, Tarricone E, Ghirardello A, Gorza L. Myofiber stress-response in myositis: parallel investigations on patients and experimental animal models of muscle regeneration and systemic inflammation. Arthritis Res Ther 2010 Mar 24; 12: R52.

147. Losada I, Sartori L, Di Gianantonio E, Zen M, Clementi M, Doria A. Bisphosphonates in patients with autoimmune rheumatic diseases: Can they be used in women of childbearing age? Autoimmun Rev 2010; 9: 547-52.

148. Zen M, Ghirardello A, Iaccarino L, Tonon M, Campana C, Arienti S, Rampudda M, Canova M, Doria A. Hormones, immune response, and pregnancy in healthy women and SLE patients. Swiss Med Wkly 2010; 140(13-14): 187-201.

149. Pisoni CN, Brucato A, Ruffatti A, Espinosa G, Cervera R, Belmonte M, Sánchez Román J, Montero Banvidez P, Tincani A, Bertero MT, Doria A, Hughes GRV, Khamashta MA. Failure of Intravenous Immunoglobulin to prevent Congenital Heart Block. Arthritis Rheum 2010; 62: 1147-52.

150. Ginzler EM, Wofsy D, Isenberg D, Gordon C, Lisk L, Dooley MA; ALMS Group: Abud C, Adler S, Alarcón G, Albuquerque E, Almeida F, Alvarellos A, Appel G, Avila H, Blume C, Boletis I, Bonnardeaux A, Braun A, Buyon J, Cervera R, Chen N, Chen S, Contreras G, Da Costa AG, Davids R, D'Cruz D, De Ramón E, Deodhar A, Dooley MA, Doria A, Dussol B, Emery P, Fiechtner J, Floege J, Fragoso-Loyo H, Furie R, Ghazalli R, Ghossein C, Gilkeson G, Ginzler E, Gordon C, Grossman J, Gu J, Guillevin L, Hatron PY, Herrera G, Hiepe F, Houssiau F, Hübscher O, Hura C, Kaplan J, Kirsztajn G, Kiss E, Kutty GA, Laville M, Lazaro M, Lenz O, Li L, Lightstone L, Lim S, Malaise M, Manzi S, Marcos J, Meyer O, Monge P, Naicker S, Neal N, Neuwelt M, Nicholls K, Olsen N, Ordi-Ros J, Ostrov B, Pestana M, Petri M, Pokorny G, Pourrat J, Qian J, Radhakrishnan J, Rovin B, Sanchez-Guerrero J, Roman JS, Shanahan J, Shergy W, Skopouli F, Spindler A, Striebich C, Sundel R, Swanepoel C, Tan SY, Tate G, Tesar V, Tikly M, Wang H, Yahya R, Yu X, Zhang F, Zoruba D. Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial. Arthritis Rheum 2010; 62: 211-21.

151. Ometto F, Botsios C, Raffeiner B, Sfriso P, Bernardi L, Todesco S, Doria A, Punzi L. Methods used to assess remission and low disease activity in rheumatoid arthritis. Autoimmun Rev 2010; 9:161-4.

152. Zampieri S, Adami N, Biral D, Ghirardello A, Rampudda ME, Vecchiato M, Savastano S, Corbianco S, Kern H, Carraro U, Bassetto F, Merigliano S, Doria A. Polymyositis, dermatomyositis and malignancy: A further intriguing link. Autoimmun Rev 2010; 9: 449-53.

153. Sfriso P, Ghirardello A, Botsios C, Tonon M, Zen M, Bassi N, Bassetto F, Doria A. Infections and autoimmunity: the multifaceted relationship. J Leukoc Biol 2010; 87(3): 385-95.

154. Zampieri S, Doria A, Adami N, Biral D, Vecchiato M, Savastano S, Corbianco S, Carraro U, Merigliano S. Subclinical myopathy in patients affected with newly diagnosed colorectal cancer at clinical onset of disease: evidence from skeletal muscle biopsies. Neurol Res 2010; 32(1): 20-5.

18

155. Ghirardello A, Briani C, Lucchetta M, Doria A. Anti-ribosomal P protein antibodies and neuropsychiatric systemic lupus erythematosus: cross-sectional vs. prospective studies. Lupus 2010; 19(6):771-3.

156. Mosca M, Tani C, Aringer M, Bombardieri S, Boumpas D, Brey R, Cervera R, Doria A, Jayne D, Khamashta MA, Kuhn A, Gordon C, Petri M, Rekvig OP, Schneider M, Sherer Y, Shoenfeld Y, Smolen JS, Talarico R, Tincani A, van Vollenhoven RF, Ward MM, Werth VP, Carmona L. EULAR Recommendations for monitoring systemic lupus erythematosus patients in clinical practice and in observational studies. Ann Rheum Dis 2010; 69(7): 1269-74.

157. Bassetto F, Vindigni V, Scarpa C, Doria A. Breast Prostheses and Connective Tissue Disease (CTD): Myth or Reality? Anesthetic Plast Surg 2010; 34(3):257-63.

158. Doria A. Atherosclerosis and lupus: what we know and what we should know. J Rheumatol 2009; 36(11):2380-2.

159. Bassi N, Zampieri S, Ghirardello A, Tonon M, Zen M, Beggio S, Matsuura E, Doria A. oxLDL/beta2GPI complex and anti-oxLDL/beta2GPI in SLE: prevalence and correlates. Autoimmunity 2009; 42: 289-91.

160. Appel GB, Contreras G, Dooley MA, Ginzler EM, Isenberg D, Jayne D, Li LS, Mysler E, Sánchez-Guerrero J, Solomons N, Wofsy D; Aspreva Lupus Management Study Group (Abud C, Adler S, Alarcón G, Albuquerque E, Almeida F, AlvarellosA, Appel G, Avila H, Blume C, Boletis I, Bonnardeaux A, Braun A, Buyon J, Cervera R, Chen N, Chen S, Contreras G, Da Costa AG, Davids R, D'Cruz D, De Ramón E, Deodhar A, Dooley MA, Doria A, Dussol B, Emery P, Fiechtner J, Floege J, Fragoso-Loyo H, Furie R, Ghazalli R, Ghossein C, Gilkeson G, Ginzler E, Gordon C, Grossman J, Gu J, Guillevin L, Hatron PY, Herrera G, Hiepe F, Houssiau F, Hübscher O, Hura C, Kaplan J, Kirsztajn G, Kiss E, Kutty GA, Laville M, Lazaro M, Lenz O, Li L, Lightstone L, Lim S, Malaise M, Manzi S, Marcos J, Meyer O, Monge P, Naicker S, Neal N, Neuwelt M, Nicholls K, Olsen N, Ordi-Ros J, Ostrov B, Pestana M, Petri M, Pokorny G, Pourrat J, Qian J, Radhakrishnan J, Rovin B, Sánchez-Guerrero J, Sanchez Roman J, Shanahan J, Shergy W, Skopouli F, Spindler A, Striebich C, Sundel R, Swanepoel C, Tan SY, Tate G, Tesaŕ V, Tikly M, Wang H, Yahya R, Yu X, Zhang F, Zoruba D. Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. J Am Soc Nephrol 2009; 20(5): 1103-12.

161. Turiel M, Atzeni F, Tomasoni L, de Portu S, Delfino L, Bodini BD, Longhi M, Sitia S, Bianchi M, Ferrario P, Doria A, Colonna VD, Sarzi-Puttini P. Non-invasive assessment of coronary flow reserve and ADMA levels: a case-control study of early rheumatoid arthritis patients. Rheumatology (Oxford) 2009; 48: 834-9.

162. Ghirardello A, Bendo R, Rampudda ME, Bassi N, Zampieri S, Doria A. Commercial blot assays in the diagnosis of systemic rheumatic diseases. Autoimmun Rev 2009; 8(8):645-9.

163. Vidalino L, Doria A, Quarta S, Zen M, Gatta A, Pontisso P. SERPINB3, apoptosis and autoimmunity. Autoimmun Rev 2009; 9: 108-12.

164. Gordon C, Jayne D, Pusey C, Adu D, Amoura Z, Aringer M, Ballerin J, Cervera R, Calvo-Alén J, Chizzolini C, Dayer J, Doria A, Ferrario F, Floege J, Guillevin L, Haubitz M, Hiepe F, Houssiau F, Lesavre P, Lightstone L, Meroni P, Meyer O, Moulin B, O'Reilly K, Praga M, Schulze-Koops H, Sinico R, Smith K, Tincani A,

19

Vasconcelos C, Hughes G. European consensus statement on the terminology used in the management of lupus glomerulonephritis. Lupus 2009;18(3):257-263.

165. Briani C, Lucchetta M, Ghirardello A, Toffanin E, Zampieri S, Ruggero S, Scarlato M, Quattrini A, Bassi N, Ermani M, Battistin L, Doria A. Neurolupus is associated with anti-ribosomal P protein antibodies: An inception cohort study. J Autoimmun 2009; 32(2): 79-84.

166. Moroni G, Doria A, Ponticelli C. Cyclosporine (CsA) in lupus nephritis: assessing the evidence. Nephrol Dial Transplant 2009; 24(1): 15-20.

167. Bassi N, Zampieri S, Ghirardello A, Tonon M, Zen M, Cozzi F, Doria A. Pentraxins, Anti-pentraxin Antibodies, and Atherosclerosis. Clin Rev Allergy Immunol 2009; 37: 36-43.

168. Ruffatti A, Del Ross T, Ciprian M, Nuzzo M, Rampudda M, Bertero MT, Bergia R, Caramaschi P, Biasi D, Capsoni F, Montaguti L, Ruffini R, Brucato A, Picillo U, Fanelli V, Riccieri V, Piccoli A, Valesini G, Doria A, Meroni PL, and Tincani A. Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicenter retrospective follow-up study. Ann Rheum Dis 2009; 68: 397-9.

169. Imbasciati E, Tincani A, Gregorini G, Doria A, Moroni G, Cabiddu G, Marcelli D. Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome. Nephrol Dial Transplant 2009; 24(2): 519-25.

170. Imazio M, Brucato A, Doria A, Brambilla G, Ghirardello A, Romito A, Natale G, Palmieri G, Trinchero R, Adler Y. Antinuclear antibodies in recurrent idiopathic pericarditis: Prevalence and clinical significance. Int J Cardiol 2009; 136: 289-93.

171. Doria A, Briani C. Primary prevention of systemic lupus erythematosus. Nat Clin Pract Rheumatol 2008; 4(11): 576-7.

172. Doria A, Sarzi-Puttini P, Shoenfeld Y. Infections, rheumatism and autoimmunity: the conflicting relationship between humans and their environment. Autoimmun Rev 2008; 8(1):1-4.

173. Doria A, Canova M, Tonon M, Zen M, Rampudda E, Bassi N, Atzeni F, Zampieri S, Ghirardello A. Infections as triggers and complications of systemic lupus erythematosus. Autoimmun Rev 2008; 8(1):24-8.

174. Doria A, Zampieri S, Sarzi-Puttini P. Exploring the complex relationships between infections and autoimmunity. Autoimmun Rev 2008; 8(2): 89-91.

175. Brucato A, Maestroni S, Cumetti D, Thiella G, Alari G, Brambilla G, Imazi M, Doria A, Palmieri G, Adler Y. Recurrent pericarditis: infectious or autoimmune? Autoimmun Rev 2008; 8(1): 44-7.

176. Doria A, Tincani A, Lockshin M. Challenges of lupus pregnancies. Rheumatology (Oxford) 2008; 47: iii9-iii12.

177. Doria A, Bajocchi G, Tonon M, Salvarani C. Pre-pregnancy counselling of patients with vasculitis. Rheumatology (Oxford) 2008; 47: iii13-iii15.

178. Æstensen M, Lockshin M, Doria A, Valesini G, Meroni P, Gordon C, Brucato A, Tincani A.Update on safety during pregnancy of biological agents and some immunosuppressive antirheumatic drugs. Rheumatology (Oxford) 2008; 47: iii28-iii31.

20

179. Cooke A, Ferraccioli G, Herrmann M, Romani L, Schulze C, Zampieri S, Doria A. Induction and protection of autoimmune rheumatic diseases: the role of infections. Clin Exp Rheumatol 2008; 26 (Suppl. 48): S1-S7.

180. Claesson MH, Nicoletti F, Stosic-Grujicic S, Doria A, Zampieri S. Interactions between infections and immune-inflammatory cells in type i diabetes mellitus and inflammatory bowel diseases: evidences from animal models. Clin Exp Rheumatol 2008; 26 (Suppl. 48): S8-S11.

181. Girschick HJ, Guilherme L, Inman RD, Latsch K, Rihl M, Sherer Y, Shoenfeld Y, Zeidler H, Arienti S, Doria A. Bacterial triggers and rheumatic diseases. Clin Exp Rheumatol 2008; 26 (Suppl. 48): S12-S17.

182. Avcin T, Canova M, Guilpain P, Guillevin L, Kallenberg CGM, Tincani A, Tonon M, Zampieri S, Doria A. Infections, connective tissue diseases and vasculitis. Clin Exp Rheumatol 2008; 26 (Suppl. 48): S18-S26.

183. Efthimiou P, Flavell RA, Furlan A, Gasbarrini G, Gava A, Koné-Paut I, Manna R, Punzi L, Sutterwala FS, Touitou I, Doria A. Autoinflammatory syndromes and infections: pathogenetic and clinical implications. Clin Exp Rheumatol 2008; 26 (Suppl. 48): S53-S61.

184. Lalvani A, Meroni PL, Millington KA, Modolo ML, Plebani M, Tincani A, Villalta D, Doria A, Ghirardello A. Recent advances in diagnostic technology: applications in autoimmune and infectious diseases. Clin Exp Rheumatol 2008; 26 (Suppl. 48): S62-S66.

185. Zara G, Ermani M, Rondinone R, Arienti S, Doria A. Thalidomide and sensory neurotoxicity: A neurophysiological study. J Neurol Neurosur Ps 2008; 79(11): 1258-61.

186. Zampieri S, Biral D, Adami N, Ghirardello A, Rampudda ME, Tonello M, Doria A. Expression of myositis specific autoantigens during post-natal myogenesis. Neurol Res 2008; 30: 145-8.

187. Doria A, Briani C. Lupus: improving long-term prognosis. Lupus 2008; 17: 166-70. 188. Bassi N, Amital D, Amital H, Doria A, Shoenfeld Y. Chronic fatigue syndrome:

characteristics and possible causes for its pathogenesis. Isr Med Assoc J 2008; 10: 79-82.

189. Shoenfeld Y, Zandman-Goddard G, Stojanovich L, Cutolo M, Amital H, Levy Y, Abu-Shakra M, Barzilai O, Berkun Y, Blank M, de Carvalho JF, Doria A, Gilburd B, Katz U, Krause I, Langevitz P, Orbach H, Pordeus V, Ram M, Toubi E, Sherer Y. The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases--2008. Isr Med Assoc J 2008; 10: 8-12.

190. Foti R, Leonardi R, Rondinone R, Di Gangi M, Leonetti C, Canova M, Doria A. Scleroderma-like disorders. Autoimmun Rev 2008; 7: 331-9.

191. Doria A, Arienti S, Rampudda M, Canova M, Tonon M, Sarzi-Puttini P. Preventive strategies in systemic lupus erythematosus. Autoimmun Rev 2008; 7: 192-7.

192. Atzeni F, Doria A, Ghirardello A, Turiel M, Batticciotto A, Carrabba M, Sarzi-Puttini P. Anti-thyroid antibodies and thyroid dysfunction in rheumatoid arthritis: prevalence and clinical value. Autoimmunity 2008; 41: 111-5.

193. Briani C, Doria A, Ruggero S, Toffanin E, Luca M, Albergoni MP, D'Odorico A, Grassivaro F, Lucchetta M, De Lazzari F, Balzani I, Battistin L, Vernino S.

21

Antibodies to muscle and ganglionic acetylcholine receptors (AchR) in celiac disease. Autoimmunity 2008; 41: 100-4.

194. Atzeni F, Doria A, Ghirardello A, Villalta D, Zampieri S, Carrabba M, Sarzi-Puttini P. Organ-specific autoantibodies in patients with rheumatoid arthritis treated with adalimumab: a prospective long-term follow-up. Autoimmunity 2008; 41: 87-91.

195. Sarzi-Puttini P, Atzeni F, Di Franco M, Lama N, Batticciotto A, Iannuccelli C, Dell'Acqua D, de Portu S, Riccieri V, Carrabba M, Buskila D, Doria A, Valesini G. Anti-polymer antibodies are correlated with pain and fatigue severity in patients with fibromyalgia syndrome. Autoimmunity 2008; 41: 74-9.

196. Sarzi-Puttini P, Doria A. Organ specific-autoantibodies: their role as markers and predictors of disease. Autoimmunity 2008; 41: 1-10.

197. Sarzi-Puttini P, Buskila D, Carabba M, Doria A, Atzeni F. Treatment strategy in Fibromyalgia syndrome: where are we now? Semin Arthritis Rheum 2008; 37(6): 353-65.

198. Bassi N, Ghirardello A, Iaccarino L, Zampieri S, Rampudda ME, Atzeni F, Sarzi-Puttini P, Shoenfeld Y, Doria A. OxLDL/β2GPI-anti-oxLDL/β2GPI complex and atherosclerosis in SLE patients. Autoimmunity Rev 2007; 7(1) :52-8.

199. Iaccarino L, Arienti S, Rampudda M, Canova M, Atzeni F, Sarzi Puttini P, Doria A. Mycophenolate mofetil in lupus glomerulonephritis: effectiveness and tolerability. Ann N Y Acad Sci 2007; 1110:516-24.

200. Shoenfeld Y, Szyper-Kravitz M, Witte T, Doria A, Tsutsumi A, Tatsuya A, Dayer JM, Roux-Lombard P, Fontao L, Kallenberg CG, Bijl M, Matthias T, Fraser A, Zandman-Goddard G, Blank M, Gilburd B, Meroni PL. Autoantibodies against protective molecules--C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus. Ann N Y Acad Sci 2007;1108: 227-39.

201. Atzeni F, Doria A, Sarzi-Puttini P. What is the role of rituximab in the treatment of rheumatoid arthritis? Autoimm Rev 2007; 6(8): 553-8.

202. Atzeni F, Doria A, Carrabba M, Turiel M, Sarzi-Puttini P. Potential terget of Infliximab in autoimmune and inflammatory diseases. Autoimm Rev 2007; 6(8): 529-36.

203. Zampieri S, Ghirardello A, Rossini K, Iaccarino L, Bassi N, Atzeni F, Sarzi-Puttini P, Doria A. Antigen preparation for immunological studies in systemic autoimmune diseases. Ann N J Acad Sci 2007; 1109: 193-202.

204. Ghirardello A, Villalta D, Morozzi G, Afeltra A, Galeazzi M, Gerli R, Mathieu A, Meroni P, Migliorini P, Radica A, Ricceri V, Ruffatti A, Sebastiani GD, Tincani A, Doria A, on Behalf of FIRMA Group. Evaluation of current methods for the m easurement of serum anti-double-stranded DNA antibodies. Ann N J Acad Sci 2007; 1109: 401-406.

205. Ghirardello A, Bizzaro N, Zampieri S, Iaccarino L, Bassi N, Tozzoli R, Ruffatti A, Villalta D, Tonutti E, Doria A. Biological and clinical relevance of anti-prothrombin antibodies. Ann N Y Acad Sci 2007;1109:503-10.

206. Orbach H, Zandman-Goddard G, Amital H, Barak V, Szekanecz Z, Szucs G, Danko K, Nagy E, Csepany T, Carvalho JF, Doria A, Shoenfeld Y. Novel Biomarkers in Autoimmune Diseases: Prolactin, Ferritin, Vitamin D, and TPA Levels in Autoimmune Diseases. Ann N Y Acad Sci. 2007; 1109:385-400.

22

207. Bizzarro N, Ghirardello A, Zampieri S, Iaccarino L, Tozzoli R, Ruffatti A, Villalta D, Doria A. Anti-prothrombin antibodies predict thrombosis in patients with systemic lupus erythematosus: a 15-year longitudinal study. J Thromb Haemost 2007 5(6):1158-64.

208. Mosca M, Strigini F, Doria A, Iaccarino L, Pratesi F, Tani C, Zampieri S, D Chimenti, Ghirardello A, Carmignani A, Cecchi M, Migliorini P, Bombardieri S. Anti-C1q antibodies in pregnant patients with systemic lupus erythematosus. Clin Exp Rheumatol 2007: 25(3):449-52.

209. Gerosa M, Cimaz R, Stramba-Badiale M, Goulene K, Meregalli E, Trespidi L, Acaia B, Tincani A, Danieli E, Motta M, Doria A, Zulian F, Brucato A, Riboldi P, Meroni PL. Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases: a multicenter prospective study. Rheumatology 2007: 46(8): 1285-9.

210. Iaccarino L, Rampudda ME, Canova M, Della Libera S, Sarzi-Puttini P; Doria A. Mycophenolate mofetil: what is its place in the treatment of autoimmune rheumatic diseases? Autoimmunity Rev 2007 6(3):190-5.

211. Moroni G, Doria A, Mosca M, Alberighi OD, Ferraccioli G, Todesco S, Manno C, Altieri P, Ferrara R, Greco S, Ponticelli C. A Randomized Pilot Trial Comparing Cyclosporine and Azathioprine for Maintenance Therapy in Diffuse Lupus Nephritis over Four Years. Clin J Am Soc Nephrol 2006;1: 925-32.

212. Hengstman GJD, ter Laak HJ, Vree Egberts WTM, Lundberg IE, Moutsopoulos HM, Vencovsky J, Doria A, Mosca M, van Venrooij WJ, van Engelen BGM. Anti-SRP autoantibodies, marker of a necrotizing myopathy. Ann Rheum Dis 2006; 65: 1635-1638.

213. Doria A, Iaccarino L, Arienti S, Rampudda ME, Canova MG, Rondinone R, Todesco S. Mycophenolate mofetil and systemic lupus erythematosus. Lupus 2006; 15 Supplement: 44-54.

214. Shoenfeld Y, Howard JA. Carp HJA, Molina V, Blank M, Cervera R, Tincani A, Faden D, Lojacono A, Doria A, Konova E, Meroni PL. Autoantibodies and Prediction of Reproductive Failure. Am J Reprod Immunol 2006; 337-44.

215. Briani C, Doria A, Marcolongo R, Tognon S, Ruggero S, Toffanin E, Ermani M Ghirardello A, Zampieri S, Semenzato G. Increased titres of IgM anti-heparan sulfate antibody in Behçet’s Disease. Clin Exp Rheumatol 2006; 24(5 Suppl 42): S104-7.

216. Tincani A, Danieli E, Nuzzo M, Scarsi M, Motta M, Cimaz R, Lojacono A, Nacinovich R, Taddei F, Doria A, Brucato A, Meroni PL and for the Pregnancy Study Group of Italian Society of Rheumatology. Impact of in utero environment on the offspring of lupus patients. Lupus 2006; 15: 801-7.

217. Doria A, Sfriso P. Adalimumab in Psoriatic Arthritis. Drugs 2006; 66: 1497-99. 218. Østensen M, Khamashta M, Lockshin M, Parke A, Brucato A, Carp H, Doria A, Rai

R, Meroni PL, Cetin I, Derksen R, Branch W, Motta M, Gordon C, Ruiz-Irastorza G, Spinillo A, Friedman D, Cimaz R, Czeizel A, Piette JC, Cervera R, Levy R, Clementi M, De Carolis S, Petri M, Shoenfeld Y, Faden D, Valesini G, Tincani A. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 2006; 8 (3): 209 (Epub ahead of print).

23

219. Doria A, Iaccarino L, Ghirardello A, Zampieri S, Arienti S, Sarzi-Puttini P, Atzeni F, Piccoli A, Todesco S. Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med 2006; 119: 1497-1499.

220. Doria A, Iaccarino L, Arienti S, Ghirardello A, Zampieri S, Rampudda ME, Cutolo M, Tincani A, Todesco S. Th2 immune deviation induced by pregnancy: the two faces of autoimmune rheumatic diseases. Reprod Toxicol 2006; 22(2): 234-241.

221. Sarzi-Puttini P, Atzeni F, Diana A, Doria A, Furlan R. Increased Neural Sympathetic Activation in Fibromyalgia syndrome. Ann NY Acad Sci 2006; 1069: 109-17.

222. Doria A, Iaccarino L, Sarzi-Puttini P, Ghirardello A, Zampieri S, Arienti S, Cutolo M, Todesco S. Estrogens in Pregnancy and systemic lupus erythematosus. Ann NY Acad Sci 2006; 1069: 247-56.

223. Tarricone E, Ghirardello A, Zampieri S, Rampudda ME, Doria A, Gorza L. Cell stress-response in skeletal muscle myofibers. Ann NY Acad Sci 2006; 1069: 472-6.

224. Briani C, Doria A, Sarzi-Puttini P, Dalakas MC. Update on idiopathic inflammatory myopathies. Autoimmunity. 2006 May;39(3):161-70.

225. Zampieri S, Ghirardello A, Iaccarino L, Briani C, Sarzi-Puttini P, Atzeni F, Arienti S, Todesco S, Doria A. Polymyositis-dermatomyositis and infections. Autoimmunity 2006; 39(3): 191-6.

226. Ghirardello A, Zampieri S, Tarricone E, Iaccarino L, Bendo R, Briani C, Rondinone R, Sarzi-Puttini P, Todesco S, Doria A. Clinical implications of autoantibody screening in patients with autoimmune myositis. Autoimmunity 2006; 39(3): 217-21.

227. Doria A, Iaccarino L, Ghirardello A, Arienti S, Zampieri S, Rampudda ME, Tincani

A, Todesco S. Seltene autoimmune rheumatische erkrankungen in der schwangerschaft: systemische sklerose, dermato-polymyositis und vaskulitiden. Z Rheumatol 2006; 65: 200-208.

228. Brucato A, Brambilla G, Moreo A, Alberti A, Munforti C, Ghirardello G, Doria

A,

Shinar Y, Livneh

A, Adler

Y, Shoenfeld

Y, Palmieri G, Spodick DH. Long term

outcomes in difficult to treat recurrent pericarditis. Am J Cardiol 2006; 98(2): 267-271.

229. Rinaldi S, Ghisi M, Iaccarino L, Zampieri S, Ghirardello A, Sarzi-Puttini P, Perini G, Todesco S, Sanavio E, Doria A. Influence of coping skills on health-related quality of life in SLE patients. Arthritis Rheum 2006; 55: 427-33.

230. Tincani A, Bompane D, Danieli E, Doria A. Pregnancy, lupus and antiphosphpolipid syndrome (Huges syndrome). Lupus 2006; 15: 156-60.

231. Drosera M, Facchetti F, Landolfo S, Mondini M, Nyberg F, Parodi A, Santoro A, Zampieri S, Doria A. Role of soluble and cell surface molecules in the pathogenesis of autoimmune skin disease. Clin Exp Rheumatol 2006; 24: S7-S13.

232. Bano S, Bombardieri S, Doria A, Iaccarino L, Lehmann P, Mosca M, Rondinone R, Sontheimer RD, Kuhn A. Lupus erythematosus and the skin. Clin Exp Rheumatol 2006; 24: S26-S35.

233. Asherson RA, Francès C, Iaccarino L, Khamashta MA, Malacarne F, Piette JC, Tincani A, Doria A. The antiphospholipid antibody syndrome: diagnosis, skin manifestations and current therapy. Clin Exp Rheumatol 2006; 24: S46-S51.

24

234. Griffiths CEM, Iaccarino L, Naldi L, Olivieri I, Pipitone N, Salvarani C, Doria A. Psoriasis and psoriatic arthritis: immunological aspects and therapeutic guidelines. Clin Exp Rheumatol 2006; 24: S72-S78.

235. Galeazzi M, Gasbarrini G, Ghirardello A, Grandemange S, Hoffman HM, Manna R, Podswiadek M, Punzi L, Sebastiani GD, Touitou I, Doria A. Autoinflammatory syndromes. Clin Exp Rheumatol 2006; 24: S79-S85.

236. Hengstman GJD, Vree Egberts WTM, Seelig HP, Lundberg IE, Moutsopoulos HM, Doria A, Mosca M, Vencovsky J, van Venrooij WJ, van Engelen BGM. Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2β antigen. Ann Rheum Dis 2006; 65: 242-5.

237. Karassa FB., Afeltra A, Ambrozic A, Chang D-M, De Keyser F, Doria A, Galeazzi M, Hirohata S, Hoffman IEA, Inanc M, Massardo L, Mathieu A, Mok CC, Morozzi G, Sanna G, Spindler AJ, Tzioufas AG, Yoshio T, Ioannidis JPA. Accuracy of Anti-Ribosomal P Protein Antibody Testing for Diagnosis of Neuropsychiatric Systemic Lupus Erythematosus: An International Meta-Analysis. Arthritis Rheum 2006; 54: 312-24.

238. Doria A, Sarzi-Puttini P, Shoenfeld Y. 2nd Conference on Heart, Rheumatism and Autoimmunity, Pescara, Italy. May 19 – 20, 2005. Autoimmunity Rev 2006; 5(1):55-63.

239. Zampieri S, Alaibac M, Iaccarino L, Rondinone R, Ghirardello A, Sarzi-Puttini P, Peserico A, Doria A. TNF-{alpha} is expressed in refractory skin lesions from subacute cutaneous lupus erythematosus patients. Ann Rheum Dis 2006; 65(4): 545-8.

240. Shoenfeld Y, Gerli R, Doria A, Matsuura E, Matucci Cerinic M, Ronda N, Jara LJ, Abu-Shakra M, Meroni PL, Sherer Y. Accelerated Atherosclerosis in Autoimmune Rheumatic Diseases. Circulation 2005; 112: 3337-47.

241. Sarzi-Puttini P, Atzeni F, Iaccarino L, Doria A. Environment and systemic lupus erythematosus: an overview. Autoimmunity 2005: 38: 465-72.

242. Sarzi-Puttini P, Atzeni F, Capsoni F, Lubrano E, Doria A. Drug-induced lupus erythematosus. Autoimmunity 2005: 38: 507-18.

243. Briani C, Zara G, Rondinone R, Iaccarino L, Ruggero S, Toffanin E, Ermani M, Ghirardello A, Zampieri S, Sarzi-Puttini P, Doria A. Positive and negative effects of thalidomide on refractory cutaneous lupus erythematosus. Autoimmunity 2005: 38: 549-55.

244. Tincani A, Rebaioli CB, Frassi M, Taglietti M, Gorla R, Cavazzana I, Faden D, Taddei F, Lojacono A, Motta M, Trepidi L, Meroni P, Cimaz R, Ghirardello A, Doria A, Pisoni MP, Muscara M, Brucato A; Pregnancy Study Group of Italian Society of Rheumatology. Pregnancy and autoimmunity: maternal treatment and maternal disease influence on pregnancy outcome. Autoimmun Rev. 2005; 4(7): 423-8.

245. Doria A, Sarzi-Puttini P. Heart, rheumatism and autoimmunity: an old intriguing link. Lupus 2005; 14 (9): 643-6.

246. Brucato A, Shinar Y, Brambilla G, Robbiolo L, Ferrioli G, Patrosso MC, Zanni D, Penco S, Boiani E, Ghirardello A, Caforio ALP, Bergantin A, Tombini V, Moreo A, Ashtamkar L, Doria A, Shoenfeld Y, Livneh A. Idiopathic recurrent acute pericarditis: Familial Mediterranean Fever mutations and disease evolution in a large cohort of Caucasian patients. Lupus 2005; 14 (9): 670-4.

25

247. Doria A, Iaccarino L, Sarzi-Puttini P, Atzeni F, Turriel M, Petri M. Cardiac involvement in systemic lupus erythematosus. Lupus 2005; 14 (9): 683-6..

248. Atzeni F, Sarzi-Puttini P, Doria A, Boiardi L, Pipitone N, Salvarani C. Behçet’s disease and cardiovascular involvement. Lupus 2005; 14 (9): 723-6.

249. Turiel M, Peretti R, Sarzi-Puttini P, Atzeni F, Doria A. Cardiac imaging techniques in systemic autoimmune diseases. Lupus 2005; 14 (9): 727-31.

250. Sarzi-Puttini P, Atzeni F, Turiel M, Iaccarino L, Doria A. Tumor necrosis factor-α, biological agents and cardiovascular risk. Lupus 2005; 14 (9): 780-4.

251. Zandman-Goddard G, Blank M, Langevitz P, Slutsky L, Pras M, Levy Y, Shovman O, Witte T, Doria A, Rovensky J, Shoenfeld Y. Anti-serum amyloid component P (SAP) antibodies in SLE patients correlate with disease activity. Ann Rheum Dis 2005; 64: 1698-1702.

252. Turiel M, Sarzi-Puttini P, Peretti R, Rossi E, Atzeni F, Parsons W, Doria A. Thrombotic risk factors in primary antiphospholipid syndrome: a five-year prospective study. Stroke 2005; 36(7): 1490-4.

253. Turiel M, Sarzi-Puttini P, Peretti R, Ionizzato S, Muzzupappa S, Atzeni F, Rossi E, Doria A. Five-year follow-up by transesophageal echocardiographic studies in primary antiphospholipid syndrome. Am J Cardiol 2005; 96(4): 574-9.

254. Zampieri S, Iaccarino L, Ghirardello A, Tarricone E, Arienti S, Sarzi-Puttini Piercarlo, Gambari PF, Doria A. Systemic lupus erythematosus, atherosclerosis, and autoimmunity. Ann NY Acad Sci 2005; 1051:351-61.

255. Atzeni F, Turiel M, Capsoni F, Doria A, Meroni PL; Sarzi-Puttini P. Autoimmunity anti-TNFa agents. Ann NY Acad Sci 2005; 1051:559-69.

256. Villalta D, Tozzoli R, Bizzaro N, Tonutti E, Ghirardello A, Doria A. The relevance of autoantigen source and cutoff definition in antichromatin (nucleosome) antibody immunoassays. Ann N Y Acad Sci 2005 Jun;1050:176-84.

257. Doria A, Sherer Y, Meroni PL, Shoenfeld Y. Inflammation and accelerated atherosclerosis – Basic mechanisms. Rheum Dis Clin N Am 2005; 31: 329-54.

258. Doria A, Mosca M, Gambari PF, Bombardieri S. Defining unclassifiable connective tissue diseases: incomplete, undifferentiated or both? J Rheumatol 2005; 32: 213-5.

259. Kuhn A, Rondinone R, Doria A, Shoenfeld Y. 1st International Conference on Cutaneous Lupus Erythematosus. Düsseldorf, Germany, September 1-4, 2004. Autoimmunity Rev 2005: 4: 66-78.

260. Capsoni F, Sarzi-Puttini P, Atzeni F, Minonzio F, Bonara P, Doria A, Carrabba M. Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis. Arthritis Res Ther 2005; 7: R250-R255..

261. Zampieri S, Ghirardello A, Iaccarino L, Tarricone E, Gambari PF, Doria A. Anti-JO-1 antibodies. Autoimmunity 2005; 38: 73-78.

262. Ghirardello A, Zampieri S, Iaccarino L, Tarricone E, Gambari PF, Doria A. Anti-MI-2 antibodies. Autoimmunity 2005; 38: 79-83.

263. Atzeni F, Sarzi-Puttini P, Doria A, Iaccarino L, Capsoni F. Potential off-label use of infliximab in autoimmune and non-autoimmune diseases: a review. Autoimmunity Rev 2005; 4(3):144-52.

26

264. Ghirardello A, Doria A, Zampieri S, Tarricone E, Tozzoli R, Villalta D, Bizzaro N, Piccoli A, Gambari PF. Antinucleosome antibodies in SLE: a two-year follow-up study of 101 patients. J Autoimmunity 2004; 22: 235-40.

265. Doria A, Shoenfeld Y, Pauletto P. Premature coronary disease in systemic lupus. N Eng J Med 2004; 350(15):1571-5.

266. Marai I, Shoenfeld Y, Bizzaro N, Villalta D, Doria A, Tonutti E, Tozzoli R. IgA and IgG tissue transglutaminase antibodies in systemic lupus erythematosus. Lupus 2004; 13(4): 241-4.

267. Briani C, Zara G, Rondinone R, Della Libera S, Ermani M, Ruggero S, Ghirardello A, Zampieri S, Doria A. Thalidomide neurotoxicity: prospective study in patients with lupus erythematosus. Neurology 2004: 62: 2288-90.

268. Doria A, Sarzi Puttini PC, Shoenfeld Y. Heart Rheumatism and Autoimmunity. Milan, Italy. February 5-7, 2004. Autoimmunity Rev 2004; 3 (4): 337-354

269. Doria A, Iaccarino L, Ghirardello A, Briani C, Zampieri S, Tarricone E, Gambari PF. Pregnancy in rare autoimmune rheumatic diseases: UCTD, MCTD, myositis, systemic vasculitis, and Beçhet disease. Lupus 2004; 13 (9): 690-5.

270. Rinaldi S, Doria A, Salaffi F, Ermani M, Iaccarino L, Ghirardello A, Zampieri S, Gambari PF, Perini G. Health-related quality of life in Italian patients with systemic lupus erythematosus. I. Relationship between physical and mental dimension and impact of age. Rheumatology 2004; 43: 1574-9.

271. Doria A, Rinaldi S, Ermani M, Salaffi F, Iaccarino L, Ghirardello A, Zampieri S, Della Libera S, Perini G, Todesco S. Health-related quality of life in Italian patients with systemic lupus erythematosus. II. Role of clinical, immunological, and psychological determinants. Rheumatology 2004; 43: 1580-6.

272. Doria A, Ghirardello A, Iaccarino L, Zampieri S, Punzi L, Tarricone E, Ruffatti A, Sulli A, Sarzi Puttini PC, Gambari PF, Cutolo M. Pregnancy, cytokines and disease activity in systemic lupus erythematosus. Arthritis Rheum 2004; 51: 989-995.

273. Villata D, Romelli PB, Savina C, Bizzarro N, Bozzoli R, Tonutti E, Ghirardello A, Doria A. Anti-dsDNA antibody avidità determination by simple reliable ELISA method for SLE diagnosis and monitorino. Lupus 2003; 12: 31-36.

274. Zampieri S, Mahler M, Blüthner M, Qiu Z, Malmegrim K, Ghirardello A, Doria A, van Venrooij WJ, Raats JMH. Recombinant anti-P proteins autoantibodies isolated from a human autoimmune library: reactivity, specificity and epitope recognition. Cell Mol Life Sci 2003; 60: 588-98.

275. Doria A, Shoenfeld Y, Wu R, Gambari PF Puato M, Ghirardello A, Gilburd B, Corbanese S, Patnaik M, Zampieri S, Peter JB, Favaretto E, Iaccarino L, Sherer Y, Todesco S, Pauletto P. Risk factors for subclinical atherosclerosis in a prospective cohort of patients with Systemic Lupus Erythematosus. Ann Rheum Dis 2003, 62: 1071-77.

276. Bizzaro N, Villalta D, Tonutti E, Doria A, Tampoia M, Bassetti D, Tozzoli R. IgA AND IgG tissue transglutaminase antibody prevalence and clinical significance in connective tissue diseases, inflammatory bowel disease, and primary biliary cirrhosis. Digest Dis Sci 2003; 48: 2360-5.

277. Righi A, Schiavon F, Jablonska S, Doria A, Blasczyk M, Rondinone R, Todesco S. Intravenous immunoglobulins control scleromyxoedema. Ann Rheum Dis 2002; 61: 59-61.

27

278. Doria A, Cutolo M, Ghirardello A, Zampieri S, Vescovi F, Sulli A, Giusti M, Piccoli A, Grella P Gambari PF. Steroid hormones and disease activity during pregnancy in systemic lupus eythematosus. Arthritis Rheum 2002; 47: 202-9.

279. Casonato A, Pontara E, Doria A, Bertomoro A, Cattini MG, Gambari PF, Girolami A. Lack of multimer organization of von Willebrand factor in an acquired con Willebrand syndrome. Br J Haematol 2002; 116: 899-904.

280. Ostuni P, Botsios C, Sfriso P, Bertagnin A, Cozzi F, Doria A, Todesco S. Prevalence and clinical features of fibromyalgia in systemic lupus erythematosus, systemic sclerosis and Sjogren's syndrome. Minerva Med 2002; 93(3):203-9..

281. Franceschini F, Cavazzana I, Generali D, Quinzanini M, Ghirardello A, Doria A, Cattaneo R. Anti-Ku Antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients. J Rheumatol 2002; 29: 1393-7.

282. Ghirardello A, Caponi L, Franceschini F, Zampieri S, Gambari PF, Doria A. Diagnostic tests for antiribosomal P protein antibodies: a comparative evaluation of immunoblotting and ELISA assays. J Autoimmunity 2002; 19: 71-77.

283. Brucato A, Franceschini F, Doria A, Cimaz R, Meroni P, Tincani A, Pisoni M, Faden D, Motta M, Frassi M, Castellino G, Tombini V, Canesi B. Pathogenetic associations of maternal Anti-Ro/SSA antibodies. Lupus 2002; 11: 650-650.

284. Brucato A, Doria A, Frassi M, Castellino G, Franceschini F, Faden D, Pisoni MP, Solerte L, Muscarà M, Lojacono A, Motta M, Cavazzana I, Ghirardello A, Vescovi F, Tombini V, Cimaz R, Gambari PF, Meroni PL, Canesi B, Tincani A. Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study. Lupus 2002; 11: 716-721.

285. Zampieri S, Degen W, Ghirardello A, Doria A, van Venrooij WJ. Dephosphorylation of autoantigenic ribosomal P proteins during FAS-L induced apoptosis; a possible trigger for the development of the autoimmune response in SLE patients. Ann Rheum Dis 2001; 60: 72-76.

286. Brucato A, Frassi M, Franceschini F, Cimaz R, Faden R, Pisoni MP, Muscarà M, Vignati G, Stramba-Badiale M, Catelli L, Lojacono A, Cavazzana I, Ghirardello A, Vescovi F, Gambari PF, Doria A, Meroni PL, Tincani A.. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis:. A prospective study of 100 women. Arthritis Rheum 2001; 44: 1832-35.

287. Ghirardello A, Doria A, Zampieri S, Gambari PF, Todesco S. Autoantibodies to ribosomal P proteins in systemic lupus erythematosus. Isr Med Assoc J 2001; 3(11): 854-7.

288. Zampieri S, Ghirardello A, Doria A, Tonello M. Bendo R, Rossini K, Gambari PF. The use of Tween 20 in immunoblotting assays for the detection of autoantibodies in connective tissue diseases. J Immunol Methods 2000; 239: 1-11.

289. Ghirardello A, Doria A, Zampieri S, Gerli R, Rapizzi E, Gambari PF. Anti ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity for SLE and association with the IgG anticardiolipin antibodies. Ann Rheum Dis 2000; 59: 975-981.

290. Anselmino M, Zaninotto G, Costantini M, Ostuni PA, Ianiello A, Boccù C, Doria A, Todesco S, Ancona E. Esophageal motor function in primary Sjögren syndrome. Correlation with dysphagia and xerostomia Dig Dis Sci 1997; 42: 113-8.

28

291. George J, Gilburg B, Levy Y, Afec A, Damianovitch M, Ghirardello A, Doria A, Todesco S, Shoenfeld Y. "Autoantibody dominance" pattern following idiotypic manipulation of naive mice by immunization with anti-U1RNP antibodies. Pathobiology 1997; 65: 204-209.

292. Doria A, Biasinutto C, Ghirardello A, Sartori E, Rondinone R, Piccoli A, Veller Fornasa C, Gambari PF. Photosensitivity in systemic lupus erythematosus: laboratory testing of ARA/ACR definition. Lupus 1996; 5: 263-268.

293. Ghirardello A, Doria A, Vesco P, Vaccaro E, Bernardi C, Fagiolo U, Gambari PF. Blotting pattern of IgG Anti-(U1)RNP antibodies in mixed connective tissue disease. Rheumatol Int 1996; 16: 145-150..

294. Fiocco U, Cozzi L, Rigon C, Chieco-Bianchi F, Baldovin M, Cassisi GA, Gallo C, Doria A, Favaro MA, Piccoli A, De Candia A, Rubaltelli L, Todesco S. Arthroscopic synoviectomy in rheumatoid and psoriatic knee joint synovitis: long-term outcome. Br J Rheumatol 1996; 35: 463-470..

295. Balestrieri G, Doria A, Galeazzi M, Meroni PL, Migliorini P, Tavoni A, Tincani A, Bombardieri S. III European Conference on Systemic Lupus Erythematosus. Conference summary. Clin Exp Rheumatol 1996; 14(S-16): S3-S16.

296. Vitali C, Doria A, Tincani A, Fabbri P, Balestrieri G, Galeazzi M, Meroni PL, Migliorini P, Neri R, Bombardieri S. International survey on the management of patients with SLE. General data on the partecipating centers and the results of a questionnaire regarding mucocutaneous involvement. Clin Exp Rheumatol 1996; 14(S-16): S17-S22.

297. Tincani A, Brey R, Balestrieri G, Vitali C, Doria A, Galeazzi M, Meroni PL, Migliorini P, Neri R, Tavoni A, Bombardieri S. International survey on the management of patients with SLE. The results of a questionnaire regarding neuropsychiatric manifestations. Clin Exp Rheumatol 1996; 14(S-16): S23-S30

298. Doria A, Vitali C, Tincani A, Balestrieri G, Galeazzi M, Meroni PL, Migliorini P, Neri R, Tavoni A, Bombardieri S. International survey on the management of patients with SLE. The results of a questionnaire regarding renal involvement. Clin Exp Rheumatol 1996; 14(S-16): S23-S30.

299. Doria A, Ghirardello A, Boscaro M, Viero ML, Vaccaro E, Patrassi GM, Gambari PF. Fibrinolysis and coagulation abnormalities in systemic lupus erythematosus. Relationship with Raynaud's phenomenon, disease activity, inflammatory indices, anticardiolipin antibodies and corticosteroid therapy. Rheumatol Int 1995; 14: 207-11.

300. Ghirardello A, Doria A, Ruffatti A, Rigoli A, Vesco P, Calligaro A, Gambari PF. Antiphospholipid antibodies (aPL) in systemic lupus erythematosus (SLE). Are they specific tools for the diagnosis of aPL syndrome in SLE? Ann Rheum Dis 1994; 53: 140-2,.

301. Ghirardello A, Doria A, Gambari PF. Antiphospholipid antibodies (aPL) in systemic lupus erythematosus (SLE). Are they specific tools for the diagnosis of aPL syndrome in SLE? (Author's reply) Ann Rheum Dis 1994; 53: 619-620.

302. Doria A, Vesco P, Zulian F, Gambari PF. The 1982 ARA/ACR criteria for classification of systemic lupus erythematosus in pediatric age Clin Exp Rheumatol 1994; 12: 689-90.

29

303. Doria A, Piccoli A, Vesco P, Vaccaro E, Marson P, De Silvestro G, Ossi E, Gambari PF. Therapy of lupus nephritis: a two-year prospective study. Ann Med Interne 1994; 145: 307-311.

304. Rosada M, Fiocco U, De Silvestro G, Doria A, Cozzi L, Favaretto M, Todesco S. Effect of D-Penicillamine on T cell phenotype in scleroderma. Comparison between treated and untreared patients. Clin Exp Rheumatol 1993; 11: 143-148.

305. Vitali C, Bencivelli W, Isenberg DA, Smolen JS, Snaith ML, Sciuto M, D'Ascanio A, Bombardieri S, and the European Consensus Study Group for Disease Activity in SLE (Doria A et al.). Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. I. A descriptive analysis of 704 european lupus patients. Clin Exp Rheumatol 1992; 10: 527-39.

306. Vitali C, Bencivelli W, Isenberg DA, Smolen JS, Snaith ML, Sciuto M, Neri R, Bombardieri S, and the European Consensus Study Group for Disease Activity in SLE (Doria A et al.). Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. Clin Exp Rheumatol 1992; 10: 541-47.

307. Bencivelli W, Vitali C, Isenberg DA, Smolen JS, Snaith ML, Sciuto M, Bombardieri S, and the European Consensus Study Group for Disease Activity in SLE (Doria A et al.). Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. III. Development of a computerised clinical chart and its application to the comparison of different indices of disease activity. Clin Exp Rheumatol 1992; 10: 549-54.

308. Ramonda R, Doria A, Villanova C, Vaccaro E, Punzi L, Fasoli G, Gambari PF. Evaluation de l'atteinte cardique au cours du lupus erythemateux dissemine. etude clinique et echocardiographique. Rev Rhum 1992; 59 (12): 790-796.

309. Doria A, Di Lenardo L, Vario S, Calligaro A, Vaccaro E, Gambari PF. Cyclosporin A in a pregnant patient with systemic lupus erythematosus. Rheumatol Int 1992; 12: 77-8.

310. Doria A, Ruffatti A, Calligaro A, Del Ross T, Ghirardello A, Gambari PF. Antiphospholipid antibodies in mixed connective tissue disease. Clin Rheumatol 1992; 11: 48-50.

311. Doria A. Ghirardello A, de Zambiasi P, Ruffatti A, Gambari PF.Japanese diagnostic criteria for mixed connective tissue disease in Caucasian patients. J Rheumatol 1992; 19: 259-264.

312. Doria A, Bonavina L, Anselmino M, Ruffatti A, Favaretto A, Gambari PF, Peracchia A, Todesco S. Esophageal involvment in Mixed Connective Tissue Disease. J Rheumatol 1991; 18: 685-90.

313. Ruffatti A, Calligaro A, Del Ross T, Targa L, Ghirardello A, Doria A, Todesco S. Clinical value of a peculiar fluorescence nuclear staining in systemic sclerosis. Clin Exp Rheumatol 9: 29-34, 1991.

314. Ruffatti A, Calligaro A, Del Ross T, Bertoli MT, Doria A, Rossi L, Todesco S. Anti-double stranded DNA antibodies in the healthy elderly prevalence and characteristics. J Clin Immunol 1990;10 (6): 300-303.

30

315. Ruffatti A, Artifoni L, Glorioso S, Calligaro A, Doria A, Gambari PF, Todesco S. Prevalence of anticentromere antibody in blood relatives of anticentromere positive patients. J Rheumatol 1985; 12: 940-3.